Artemis Strategic Investment (ARTE) S-4 8 Sep 23 Registration of securities issued in business combination transactions Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Jun. 30, 2023
Document and Entity Information
Document Type	S-4
Entity Registrant Name	ARTEMIS STRATEGIC INVESTMENT CORPORATION
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Central Index Key	0001839990
Amendment Flag	false

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 03, 2021
Current assets
Cash	$ 51,409		$ 160,940				$ 953,329
Prepaid expenses	35,000		106,495				450,708
Investments held in Trust Account	189,038,189
Total Current Assets	189,124,598		267,435				1,404,037
Investments held in Trust Account	22,060,895		208,244,129				205,284,883
Total Assets	211,185,493		208,511,564				206,688,920
Current liabilities
Accounts payable and accrued expenses	7,086,211		6,210,035				396,587
Amounts due to redeemed Class A common stockholders	189,038,189
Total Current Liabilities	196,124,400		6,210,035				396,587
Derivative warrant liabilities	583,819		2,712,450				9,856,706
Deferred underwriting fee payable							6,693,750
Total Liabilities	196,708,219		8,922,485				16,947,043
Commitments and Contingencies
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at June 30, 2023 and December 31, 2022
Accumulated deficit	(6,836,728)		(7,913,028)				(15,533,626)
Total Stockholders' Deficit	(6,836,225)	$ (6,938,913)	(7,912,525)	$ (6,775,298)	$ (12,619,810)	$ (16,787,359)	(15,533,123)	$ 0
Total Liabilities and Stockholders' Deficit	211,185,493		208,511,564				206,688,920
Class A common stock
Stockholders' Deficit
Common stock	341
Class A common stock subject to possible redemption
Current liabilities
Class A common stock; 20,125,000 shares subject to possible redemption at $10.45 and $10.31 per share at June 30, 2023 and December 31, 2022, respectively	21,313,499		207,501,604				205,275,000
Class A common stock not subject to possible redemption
Stockholders' Deficit
Common stock			0				0
Class B common stock
Stockholders' Deficit
Common stock	$ 162		$ 503				$ 503

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Jun. 29, 2023	Dec. 31, 2022	Dec. 31, 2021	Oct. 04, 2021
Preferred stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000		1,000,000	1,000,000
Preferred stock, shares issued	0		0	0
Preferred stock, shares outstanding	0		0	0
Class A common stock
Common stock, redemption value per share	$ 10.49
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	380,000,000		380,000,000	380,000,000
Common stock, shares issued	3,412,816		0
Common stock, shares outstanding	3,412,816		0
Class A common stock subject to possible redemption
Common stock subject to possible redemption	2,112,027		20,125,000	20,125,000
Common stock, redemption value per share	$ 10.09		$ 10.31	$ 10.20
Class A common stock not subject to possible redemption
Common stock, shares issued			0	0
Common stock, shares outstanding			0	0
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000		20,000,000	20,000,000
Common stock, shares issued	1,618,434		5,031,250	5,031,250
Common stock, shares outstanding	1,618,434	1,618,434	5,031,250	5,031,250

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended					6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Formation and general and administrative expenses	$ 227,545			$ 781,914		$ 812,684	$ 5,054,348		$ 6,469,453	$ 282,666
Loss from operations	(227,545)			(781,914)		(812,684)	(5,054,348)		(6,469,453)	(282,666)
Other income
Interest earned on investments held in trust account	1,807,023			231,675		3,835,611	266,579		3,070,568	9,883
Transaction costs allocated to warrant liabilities										(1,154,518)
Change in fair value of warrant liabilities	619,931			5,067,788		2,128,631	8,051,082		7,144,256	1,739,419
Total other income	2,426,954		$ 1,114,342	5,299,463		5,964,242	8,317,661	$ 9,432,004	10,540,962	594,784
Income before provision for income taxes	2,199,409			4,517,549		5,151,558	3,263,313		4,071,509	312,118
Provision for income taxes	(805,478)					(1,225,175)			(591,919)
Net income	$ 1,393,931	$ 2,532,453	$ 392,193	$ 4,517,549	$ (1,254,236)	$ 3,926,383	$ 3,263,313	$ 3,655,506	$ 3,479,590	$ 312,118
Class A common stock
Other income
Weighted average shares of common stock outstanding, basic	19,588,855		20,125,000	20,125,000		19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Weighted average shares of common stock outstanding, diluted	19,588,855		20,125,000	20,125,000		19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Basic net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Class B common stock
Other income
Weighted average shares of common stock outstanding, basic	4,902,371		5,031,250	5,031,250		4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Weighted average shares of common stock outstanding, diluted	4,902,371		5,031,250	5,031,250		4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Basic net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Class A common stock Common Stock	Class B common stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Jan. 03, 2021		$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Jan. 03, 2021		0
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			(4,892,613)	(15,845,744)	(20,738,357)
Forfeiture of Class B common stock from Sponsor		$ (162)	162
Forfeiture of Class B common stock from Sponsor, (in shares)		(1,618,434)
Sale of Class B common stock to Institutional Anchor Investors		$ 162	647,954		648,116
Sale of Class B common stock to Institutional Anchor Investors, (in shares)		1,618,434
Excess cash received over the fair value of the private warrants			4,220,000		4,220,000
Net income (loss)				312,118	312,118
Balance at the end at Dec. 31, 2021		$ 503	0	(15,533,626)	(15,533,123)
Balance at the end (in shares) at Dec. 31, 2021		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income (loss)				(1,254,236)	(1,254,236)
Balance at the end at Mar. 31, 2022		$ 503		(16,787,862)	(16,787,359)
Balance at the end (in shares) at Mar. 31, 2022		5,031,250
Balance at the beginning at Dec. 31, 2021		$ 503	0	(15,533,626)	(15,533,123)
Balance at the beginning (in shares) at Dec. 31, 2021		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income (loss)					3,263,313
Balance at the end at Jun. 30, 2022		$ 503		(12,620,313)	(12,619,810)
Balance at the end (in shares) at Jun. 30, 2022		5,031,250
Balance at the beginning at Dec. 31, 2021		$ 503	0	(15,533,626)	(15,533,123)
Balance at the beginning (in shares) at Dec. 31, 2021		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income (loss)					3,655,506
Balance at the end at Sep. 30, 2022				(6,775,801)	(6,775,298)
Balance at the beginning at Dec. 31, 2021		$ 503	$ 0	(15,533,626)	(15,533,123)
Balance at the beginning (in shares) at Dec. 31, 2021		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount				4,141,008	4,141,008
Net income (loss)				3,479,590	3,479,590
Balance at the end at Dec. 31, 2022		$ 503		(7,913,028)	(7,912,525)
Balance at the end (in shares) at Dec. 31, 2022		5,031,250
Balance at the beginning at Mar. 31, 2022		$ 503		(16,787,862)	(16,787,359)
Balance at the beginning (in shares) at Mar. 31, 2022		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount				(350,000)	(350,000)
Net income (loss)				4,517,549	4,517,549
Balance at the end at Jun. 30, 2022		$ 503		(12,620,313)	(12,619,810)
Balance at the end (in shares) at Jun. 30, 2022		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount				5,452,319	5,452,319
Net income (loss)				392,193	392,193
Balance at the end at Sep. 30, 2022				(6,775,801)	(6,775,298)
Balance at the beginning at Dec. 31, 2022		$ 503		(7,913,028)	(7,912,525)
Balance at the beginning (in shares) at Dec. 31, 2022		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount				(1,558,841)	(1,558,841)
Net income (loss)				2,532,453	2,532,453
Balance at the end at Mar. 31, 2023		$ 503		(6,939,416)	(6,938,913)
Balance at the end (in shares) at Mar. 31, 2023		5,031,250
Balance at the beginning at Dec. 31, 2022		$ 503		(7,913,028)	(7,912,525)
Balance at the beginning (in shares) at Dec. 31, 2022		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income (loss)					3,926,383
Balance at the end at Jun. 30, 2023	$ 341	$ 162		(6,836,728)	(6,836,225)
Balance at the end (in shares) at Jun. 30, 2023	3,412,816	1,618,434
Balance at the beginning at Mar. 31, 2023		$ 503		(6,939,416)	(6,938,913)
Balance at the beginning (in shares) at Mar. 31, 2023		5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount				(1,291,243)	(1,291,243)
Conversion of Class B common stock to Class A common stock (in shares)	3,412,816	(3,412,816)
Conversion of Class B common stock to Class A common stock	$ 341	$ (341)
Net income (loss)				1,393,931	1,393,931
Balance at the end at Jun. 30, 2023	$ 341	$ 162		$ (6,836,728)	$ (6,836,225)
Balance at the end (in shares) at Jun. 30, 2023	3,412,816	1,618,434

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS	6 Months Ended
	Jun. 30, 2023 USD ($)
Cash flows from operating activities:
Net income	$ 3,926,383
Adjustments to reconcile net income/(loss) to net cash used in operating activities:
Interest earned on investments held in trust account	(3,835,611)
Change in fair value of warrant liabilities	(2,128,631)
Adjustments to operating assets and liabilities:
Decrease in prepaid expenses	71,495
Increase in accounts payable and accrued expenses	876,176
Net cash used in operating activities	(1,090,188)
Cash flows from investing activities:
Proceeds from Trust Account to pay for taxes	980,657
Net cash provided by investing activities	980,657
Cash flows from financing activities:
Net change in cash	(109,531)
Cash at beginning of period	160,940
Cash at end of period	51,409
Non-cash investing and financing activities:
Amounts due to redeemed Class A common stockholders	189,038,189
Cash paid for income taxes	$ 750,000

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Artemis Strategic Investment Corporation (the “ Company Business Combination As of June 30, 2023, the Company had not yet commenced any operations. All activity since inception relates to the Company’s formation and the initial public offering (the “ Initial Public Offering IPO Prior to the consummation of the IPO, on January 5, 2021, Artemis Sponsor, LLC (the “ Sponsor Founder Shares Class B Common Stock On October 4, 2021, the Company consummated the Initial Public Offering of 20,125,000 units (the “ Units Public Shares Class A Common Stock one Public Warrants Certain institutional anchor investors (the “ Institutional Anchor Investors Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,000,000 warrants (the “ Sponsor Warrants Anchor Investor Warrants Private Placement Warrants Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial Business Combination on a one-for-one basis, subject to adjustment as provided in the Company’s final prospectus, as filed with the Securities and Exchange Commission (the “ SEC Final Prospectus Transaction costs amounted to $25,559,771 consisting of $3,825,000 of underwriting fees, $7,043,750 of deferred underwriting commissions, $13,796,426 of offering costs related to the fair value of the Founder Shares issued to certain Institutional Anchor Investors and $894,595 of other offering costs. Effective as of July 14, 2022, Barclays Capital Inc. (“ Barclays BMO Following the closing of the Initial Public Offering, an amount of $205,275,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “ Trust Account Investment Company Act The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to effect a Business Combination successfully. The Company will provide its holders of the outstanding Public Shares (the “ Public Stockholders If the Company conducts redemptions of the Public Shares in connection with a Business Combination pursuant to the proxy solicitation rules in conjunction with a stockholder meeting instead of pursuant to the tender offer rules, the Company’s third amended and restated certificate of incorporation (the “ Certificate of Incorporation Exchange Act The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions, which prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ ASC If the Company is unable to conduct redemptions pursuant to the proxy solicitation rules as described above, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor, officers, directors, Institutional Anchor Investors, and advisors have agreed (a) to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment, (c) not to redeem any shares (including the Founder Shares) into cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company is unable to conduct redemptions pursuant to the proxy solicitation rules) or a vote to amend the provisions of the Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor and our officers, directors and advisors will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (or 21 months from the closing of the Initial Public Offering, if the Company has executed a definitive agreement for a Business Combination within 18 months from the closing of the Initial Public Offering) (the “ Combination Period Proposed Business Combination with Novibet On June 29, 2023, the Company held a special meeting of its stockholders in lieu of an annual meeting of stockholders (the “2023 Special Meeting”). At the 2023 Special Meeting, the Company’s stockholders approved a proposal to amend the Company’s third amended and restated certificate of incorporation (the “Certificate of Incorporation”) to provide the Company with the right to extend the date by which the Company must consummate its initial business combination (the “Extension”), from July 4, 2023 to October 4, 2023 (the “Extended Date”) and to allow the Company, without another stockholder vote, by resolution of the Company’s board of directors, to elect to further extend the Extended Date in one-month increments up to six additional times, or a total of up to nine months total, up to April 4, 2024 (the “Extension Amendment Proposal”). In connection with the Extension, the Sponsor agreed to deposit into the Trust Account as a loan, (i) on July 5, 2023, an amount equal to the lesser of (x) $180,000 or (y) $0.105 per public share multiplied by the number of public shares outstanding, and (ii) one business day following the public announcement by the Company disclosing that the Company’s board of directors has determined to further extend the date by which the Company must consummate a business combination for an additional month, for each additional month up to April 4, 2024, an amount equal to the lesser of (x) $60,000 or (y) $0.035 per public share multiplied by the number of public shares outstanding. The Company’s stockholders also approved a proposal (the “Redemption Limitation Amendment Proposal”) to amend the Certificate of Incorporation to eliminate (i) the limitation that the Company may not redeem public shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 and (ii) the limitation that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such business combination. The Company’s stockholders also approved a proposal (the “Founder Share Amendment Proposal” and together with the Extension Amendment Proposal and Redemption Limitation Amendment Proposal, the “Charter Amendment Proposals”) to provide for the right of a holder of the Company’s Class B common stock, par value $0.0001 per share, to convert such shares into Class A common stock, par value $0.0001 per share, on a one-for-one basis at any time and from time to time prior to the closing of a business combination at the election of the holder. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act The Institutional Anchor Investors will not be entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period), see Note 5. Proposed Business Combination with Novibet On March 28, 2022, the board of directors of Artemis unanimously approved the Agreement and Plan of Reorganization, dated as of March 30, 2022, and amended on September 2, 2022 and December 14, 2022 (as the same may be further amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement Komisium Novibet PubCo Merger Sub Share Exchange Merger Proposed Business Combination Pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the Effective Time, Komisium will sell and transfer all issued ordinary shares and other equity interests of Novibet to PubCo in consideration for receiving at closing of the Proposed Business Combination (a) an amount of cash, which will not exceed $50 million, equal to the excess of the Gross Closing Proceeds (as defined in the Business Combination Agreement) over $100 million (the “ Closing Cash Consideration PubCo Ordinary Shares Closing Share Consideration (“ Initial Share Premium Additional Closing Share Consideration Deferred Share Consideration Earnout Consideration Additionally, pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the effective time of the Merger (the “ Effective Time Warrant Agreement On September 2, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 1 to the Business Combination Agreement, which among other things provided for (i) a closing share valuation of $500,000,000, with 12,254,902 PubCo Ordinary Shares issuable to Komisium at closing of the Proposed Business Combination if redemptions equal or exceed 85%, or if redemptions are less than 85%, then such PubCo Ordinary Shares would be deferred and issuable in subsequent years if certain earnout targets are met, (ii) a dual tranche earnout based on the achievement of certain net gaming revenue targets, (iii) clauses permitting Komisium to transfer up to 30% of the issued PubCo Ordinary Shares after the Closing, (iv) the payment of an amount of dividend declared prior to March 30, 2022 to Komisium up to the amount of €3,579,625, (v) the payment of the net profits generated by Novibet between signing and closing to Komisium, and (vi) a minimum cash closing condition of $12.5 million after transaction expenses and redemptions. On December 14, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 2 to the Business Combination Agreement, which among other things provided for (i) the change of Pubco’s jurisdiction of incorporation from England and Wales to Jersey and (ii) clauses permitting Komisium to transfer up to 10% of the issued Novibet ordinary shares prior to the Closing Date. In connection with the execution of the Business Combination Agreement, the Sponsor, Novibet and the Company entered into a Sponsor Support Agreement on March 30, 2022 (the “ Sponsor Support Agreement The closing of the Proposed Business Combination is subject to certain closing conditions and there is no assurance that the Proposed Business Combination will be completed. On June 2, 2023, the Company informed Novibet, Komisium, and the other parties to the Business Combination Agreement of its decision to terminate the Business Combination Agreement, with immediate effect. The termination was made pursuant to the Business Combination Agreement. In addition, pursuant to the Sponsor Support Agreement, the termination of the Business Combination Agreement also terminated the Sponsor Support Agreement. Liquidity and Going Concern Consideration As of June 30, 2023, the Company had $51,409 in cash and a working capital deficit of $6,999,802. The Company’s liquidity needs through June 30, 2023, were satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (defined below, see Note 5). As of June 30, 2023, there were no amounts outstanding under the Working Capital Loans. The Company’s management plans to continue its efforts to complete a Business Combination, which includes the Company’s most recent announcement related to a Definitive Merger Agreement with Danam Health, Inc., via Form 8-K filed with the SEC on Monday August 7 th If the Company’s funds are insufficient to meet the expenditures required for operating its business in the attempt to find a Business Combination or in the event that an initial Business Combination is not consummated, the Company will likely need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through October 4, 2023. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be unable to raise additional capital. In connection with the vote to approve the Charter Amendment Proposals, the holders of 18,012,973 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.49 per share (the “ Redemptions	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Artemis Strategic Investment Corporation (the “ Company Business Combination As of December 31, 2022, the Company had not yet commenced any operations. All activity since inception relates to the Company’s formation and the initial public offering (the “ Initial Public Offering IPO Prior to the consummation of the IPO, on January 5, 2021, Artemis Sponsor, LLC (the “ Sponsor per share (“ Founder Shares Class B Common Stock On October 4, 2021, the Company consummated the Initial Public Offering of 20,125,000 units (the “ Units Public Shares Class A Common Stock one Public Warrants shares of Class B Common Stock were no longer subject to forfeiture. Certain institutional anchor investors (the “ Institutional Anchor Investors Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,000,000 warrants (the “ Sponsor Warrants Anchor Investor Warrants Private Placement Warrants Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial Business Combination on a one-for-one basis, subject to adjustment as provided in the Company’s final prospectus, as filed with the Securities and Exchange Commission (the “ SEC Final Prospectus Transaction costs amounted to $25,559,771 consisting of $3,825,000 of underwriting fees, $7,043,750 of deferred underwriting commissions, $13,796,426 of offering costs related to the fair value of the Founder Shares issued to certain Institutional Anchor Investors and $894,595 of other offering costs. Effective as of July 14, 2022, Barclays Capital Inc. (“ Barclays withdrew from its role as financial advisor and capital markets advisor to the Company and waived its entitlement to all fees in connection with the Business Combination, including its portion of the deferred underwriting commissions in the amount of approximately $4,578,438. Effective as of July 20, 2022, BMO Capital Markets Corp. (“ BMO $13,158,020 $638,407 Following the closing of the Initial Public Offering, an amount of $205,275,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “ Trust Account Investment Company Act The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to effect a Business Combination successfully. The Company will provide its holders of the outstanding Public Shares (the “ Public Stockholders If the Company conducts redemptions of the Public Shares in connection with a Business Combination pursuant to the proxy solicitation rules in conjunction with a stockholder meeting instead of pursuant to the tender offer rules, the Company’s third amended and restated certificate of incorporation (the “ Certificate of Incorporation Exchange Act The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions, which prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ ASC If the Company is unable to conduct redemptions pursuant to the proxy solicitation rules as described above, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor, officers, directors, Institutional Anchor Investors, and advisors have agreed (a) to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment, (c) not to redeem any shares (including the Founder Shares) into cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company is unable to conduct redemptions pursuant to the proxy solicitation rules) or a vote to amend the provisions of the Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor and our officers, directors and advisors will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (or 21 months from the closing of the Initial Public Offering, if the Company has executed a definitive agreement for a Business Combination within 18 months from the closing of the Initial Public Offering) (the “ Combination Period Proposed Business Combination with Novibet The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act The Institutional Anchor Investors will not be entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period), see Note 5. Proposed Business Combination with Novibet On March 28, 2022, the board of directors of Artemis unanimously approved the Agreement and Plan of Reorganization, dated as of March 30, 2022, and amended on September 2, 2022 (as the same may be further amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement Komisium Novibet PubCo Merger Sub Share Exchange Merger Proposed Business Combination Pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the Effective Time, Komisium will sell and transfer all issued ordinary shares and other equity interests of Novibet to PubCo in consideration for receiving at closing of the Proposed Business Combination (a) an amount of cash, which will not exceed $50 million, equal to the excess of the Gross Closing Proceeds (as defined in the Business Combination Agreement) over $100 million (the “ Closing Cash Consideration PubCo Ordinary Shares Closing Share Consideration Initial Share Premium Additional Closing Share Consideration Deferred Share Consideration Earnout Consideration Additionally, pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the effective time of the Merger (the “ Effective Time share of Class A Common Stock subject to the terms of the Company’s Certificate of Incorporation and the Sponsor Support Agreement, (b) each issued and outstanding share of Class A Common Stock (including the shares of Class A Common Stock issued upon conversion of shares of Class B Common Stock, but not including any shares redeemed by the Public Stockholders and certain other excluded Company shares) shall no longer be outstanding and will be automatically converted into the right of the holder thereof to receive Warrant Agreement On September 2, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 1 to the Business Combination Agreement, which among other things provided for (i) a closing share valuation of $500,000,000, with 12,254,902 PubCo Ordinary Shares issuable to Komisium at closing of the Proposed Business Combination if redemptions equal or exceed 85%, or if redemptions are less than 85%, then such PubCo Ordinary Shares would be deferred and issuable in subsequent years if certain earnout targets are met, (ii) a dual tranche earnout based on the achievement of certain net gaming revenue targets, (iii) clauses permitting Komisium to transfer up to 30% of the issued PubCo Ordinary Shares after the Closing, (iv) the payment of an amount of dividend declared prior to March 30, 2022 to Komisium up to the amount of €3,579,625, (v) the payment of the net profits generated by Novibet between signing and closing to Komisium, and (vi) a minimum cash closing condition of $12.5 million after transaction expenses and redemptions. On December 14, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 2 to the Business Combination Agreement, which among other things provided for (i) the change of Pubco’s jurisdiction of incorporation from England and Wales to Jersey and (ii) clauses permitting Komisium to transfer up to 10% of the issued Novibet ordinary shares prior to the Closing Date. In connection with the execution of the Business Combination Agreement, the Sponsor, Novibet and the Company entered into a Sponsor Support Agreement on March 30, 2022 (the “ Sponsor Support Agreement The closing of the Proposed Business Combination is subject to certain closing conditions and there is no assurance that the Proposed Business Combination will be completed. Liquidity and Going Concern Consideration As of December 31, 2022, the Company had $160,940 in cash and a working capital deficit of $5,942,600. The Company’s liquidity needs through December 31, 2022, were satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (defined below, see Note 5). As of December 31, 2022, there were no amounts outstanding under the Working Capital Loans. The Company’s management plans to continue its efforts to complete a Business Combination within 21 months of the closing of the Initial Public Offering, or July 4, 2023. If the Company’s funds are insufficient to meet the expenditures required for operating its business in the attempt to find a Business Combination or in the event that an initial Business Combination is not consummated, the Company will likely need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through July 4, 2023. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be unable to raise additional capital.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2023. The interim results for the three months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of June 30, 2023 and December 31, 2022, 2,112,027 and 20,125,000 shares of Class A common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company had $1,589,736 and $1,316,585 of deferred income tax assets at June 30, 2023 and December 31, 2022, respectively, and a full valuation allowance at the end of each period. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. As of June 30, 2023 and December 31, 2022, income taxes payable of $647,396 and $591,919, respectively, are included in accounts payable and accrued expenses on the Company’s condensed balance sheet. Net Income/(Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income/(Loss) per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income/(Loss) is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. On June 29, 2023, the Company issued an aggregate of 3,412,816 shares of non-redeemable Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (“Founder Share Conversion”). The 3,412,816 shares of non-redeemable Class A common stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B common stock before the Founder Share Conversion (see Note 5). The Company’s basic and diluted income/(loss) per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended Six Months Ended Six Months Ended ​ ​ June 30, 2023 ​ June 30, 2022 ​ June 30, 2023 ​ June 30, 2022 Class A Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class A Common Stock ​ $ 1,115,145 ​ $ 3,614,039 ​ $ 3,141,106 ​ $ 2,610,650 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 19,588,855 ​ ​ 20,125,000 ​ 19,745,490 ​ ​ 20,125,000 Net income/(loss) per share, Class A, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class B common stock ​ $ 278,786 ​ $ 903,510 ​ ​ 785,277 ​ ​ 652,662 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 4,902,371 ​ ​ 5,031,250 ​ 4,938,965 ​ ​ 5,031,250 Net income/(loss) per share, Class B, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 (including deferred underwriting commissions of an aggregate of approximately $ 7,043,750 which, prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters of the IPO upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively) Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ASC 815-40”). Such warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statement of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of any warrants. At that time, the portion of the warrant liabilities related to the warrants will be reclassified to additional paid-in capital. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and December 31, 2021. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of December 31, 2022 and December 31, 2021, 20,125,000 shares of Class A Common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. At December 31, 2022 the Company had $1,316,585 of deferred income tax assets and at December 31, 2021, the Company’s deferred income tax assets are deemed to be de minimis. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. Net Income per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. The Company’s basic and diluted net income per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the ​ ​ For the period from ​ ​ Year Ended ​ ​ January 4, 2021 to ​ ​ ​ December 31, 2022 ​ ​ December 31, 2021 Class A Common Stock ​ ​ ​ ​ ​ ​ Numerator: Net income allocable to Class A Common Stock ​ $ 2,783,672 ​ $ 162,830 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 20,125,000 ​ 4,947,859 Net income per share, Class A, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ Numerator: Net income allocable to Class B common stock ​ $ 695,918 ​ $ 149,288 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 5,031,250 ​ 4,536,343 Net income per share, Class B, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 was charged to temporary equity, and Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ ASC 815-40 Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 20,125,000 Units , including the 2,625,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, one Public Warrant	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 20,125,000 Units , including the 2,625,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, one Public Warrant

PRIVATE PLACEMENT

PRIVATE PLACEMENT	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased 8,000,000 Private Placement Warrants at a price of $1.00 per warrant, generating total proceeds of $8,000,000 to the Company. Substantially concurrently with the closing of the Private Placement, the Sponsor sold an aggregate of 2,000,000 Private Placement Warrants to certain Institutional Anchor Investors for at a price of $1.00 per warrant, generating total proceeds of $2,000,000 to the Company. Each Private Placement Warrant is identical to the Public Warrants in material terms and provisions, except that the Private Placement Warrants will be non-redeemable (except as described below in Note 7 under “ Redemption of Warrants for Class A Common Stock	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased 8,000,000 Private Placement Warrants at a price of $1.00 per warrant, generating total proceeds of $8,000,000 to the Company. Substantially concurrently with the closing of the Private Placement, the Sponsor sold an aggregate of 2,000,000 Private Placement Warrants to certain Institutional Anchor Investors for at a price of $1.00 per warrant, generating total proceeds of Each Private Placement Warrant is identical to the Public Warrants in material terms and provisions, except that the Private Placement Warrants will be non-redeemable (except as described below in Note 7 under “ Redemption of Warrants for Class A Common Stock

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On January 5, 2021, the Company issued 4,312,500 Founder Shares to the Sponsor in consideration for the Sponsor paying certain offering and formation costs on behalf of the Company with a value of $25,000. On March 16, 2021, the Company effected a stock split of the Founder Shares, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor. All share and per share amounts have been retroactively restated to reflect the stock split. Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Public Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days In connection with the closing of the Initial Public Offering the Sponsor sold an aggregate of 1,618,434 Founder Shares to the Institutional Anchor Investors at their original purchase price. The Company estimated the aggregate fair value of these Founder Shares attributable to the Institutional Anchor Investors to be $13,796,426, or $8.54 per share. The fair value of the Founder Shares were valued using a binomial/lattice model. The excess of the fair value of the Founder Shares over cost was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost was allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. On June 29, 2023, the Company issued an aggregate of 3,412,816 shares of non-redeemable Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (“ Founder Share Conversion Promissory Note — Related Party On January 5, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “ Note Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“ Working Capital Loans Administrative Support Agreement The Company entered into an agreement, commencing on September 30, 2021, to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative support. Upon completion of the Proposed Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 in accordance with the terms of the agreement during the three months ended June 30, 2023, incurred $60,000 and paid $20,000 in accordance with the terms of the agreement, during the six months ended June 30, 2023 and incurred and paid $30,000 and $60,000 in accordance with the terms of the agreement during the three and six months ended June 30, 2022, respectively.	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On January 5, 2021, the Company issued 4,312,500 Founder Shares to the Sponsor in consideration for the Sponsor paying certain offering and formation costs on behalf of the Company with a value of $25,000. On March 16, 2021, the Company effected a stock split of the Founder Shares, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor. All share and per share amounts have been retroactively restated to reflect the stock split. Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Public Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their Public Shares for cash, securities or other property. In connection with the closing of the Initial Public Offering the Sponsor sold an aggregate of 1,618,434 Founder Shares to the Institutional Anchor Investors at their original purchase price. The Company estimated the aggregate fair value of these Founder Shares attributable to the Institutional Anchor Investors to be $13,796,426, or $8.54 per share. The fair value of the Founder Shares were valued using a binomial/lattice model. The excess of the fair value of the Founder Shares over cost was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost was allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Promissory Note — Related Party On January 5, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “ Note Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“ Working Capital Loans Administrative Support Agreement The Company entered into an agreement, commencing on September 30, 2021, to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative support. Upon completion of the Proposed Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred and paid $120,000 and $30,000 in accordance with the terms of the agreement, during the year ended December 31, 2022 and for the period from January 4, 2021 (Inception) to December 31 2021, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of macroeconomic conditions, such as the COVID-19 pandemic, downturns in the financial markets, inflation, declines in consumer spending, increases in interest rates, and geopolitical instability such as the war in Ukraine, on the industry and has concluded that while it is reasonably possible that such macroeconomic conditions could have a negative effect on the Company’s financial position, results of its operations, search for a target company and/or the completion of a Business Combination, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, the Inflation Reduction Act of 2022 (the “ IR Act covered corporation The extent of the excise tax that may be incurred would depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the excise tax, (ii) the fair market value of the redemption treated as a repurchase of stock in connection with the Proposed Business Combination, (iii) the nature and amount of the equity issued, if any, by us in connection with the Proposed Business Combination, and (iv) the content of forthcoming regulations and other guidance from the U.S. Department of the Treasury. Although issuances of stock by a repurchasing corporation in a year in which such corporation repurchases stock may reduce the amount of excise tax imposed with respect to such repurchase, absent the issuance of applicable guidance, it is not currently expected that this reduction would be available with respect to redemptions of Class A Common Stock by the Company and the issuance of shares in connection with the Proposed Business Combination. The excise tax is imposed on the repurchasing corporation itself, not the stockholders from which shares are repurchased, and only limited guidance on the mechanics of any required reporting and payment of the excise tax on which taxpayers may rely have been issued to date. The imposition of the excise tax could reduce the amount of cash available the Company us for effecting the redemptions of Class A Common Stock, and could reduce the cash on hand for the Company (and PubCo immediately following the Proposed Business Combination) to fund operations and to make distributions to stockholders. Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement signed in connection with the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Public Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters, prior to their respective resignation and waiver of fees, were entitled to deferred underwriting commissions of $0.35 per Unit, or $7,043,750 in the aggregate. The deferred underwriting commissions were expected to become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, dated September 29, 2021, among Barclays, BMO and the Company. On July 14, 2022, Barclays delivered to the Company a notice of resignation of its roles as financial and capital markets advisor to the Company in connection with the Business Combination and waived all rights to fees (including deferred underwriting commissions for services rendered as one of the underwriters in the Company’s IPO) and reimbursement of expenses in connection with the Business Combination. On July 20, 2022, BMO, one of the underwriters in the IPO, delivered to the Company a notice that BMO waived all rights to its portion of the deferred underwriting commissions in connection with the IPO. BMO had no role in connection with the Business Combination. As a result of the Barclays’ resignation letter and BMO’s waiver notice, the Company recorded a gain on derecognition of deferred underwriting fees payable of $326,138 within the Statement of Operations and $6,717,612 was recorded as an adjustment for accretion of Class A common stock subject to possible redemption amount for the year ended December 31, 2022.	NOTE 7. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of macroeconomic conditions, such as the COVID-19 pandemic, downturns in the financial markets, inflation, declines in consumer spending, increases in interest rates, and geopolitical instability such as the war in Ukraine, on the industry and has concluded that while it is reasonably possible that such macroeconomic conditions could have a negative effect on the Company’s financial position, results of its operations, search for a target company and/or the completion of a Business Combination, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, the Inflation Reduction Act of 2022 (the “ IR Act Treasury Any repurchase by the Company of the Company’s stock that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, is generally expected to be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax on a redemption of Class A Common Stock or other stock of the Company in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the excise tax, (ii) the fair market value of the redemption treated as a repurchase of stock in connection with the Business Combination, extension or otherwise, (iii) the structure of a Business Combination, (iv) the nature and amount of any proposed “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a redemption treated as a repurchase of stock) and (v) the content of regulations and other guidance from the Treasury. As noted above, the excise tax would be payable by the Company and not by the redeeming holder. The imposition of the excise tax could cause a reduction in the cash available on hand to complete a Business Combination or for effecting redemptions and may affect the Company’s ability to complete a Business Combination, including the proposed Business Combination with Novibet. Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement signed in connection with the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Public Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters, prior to their respective resignation and waiver of fees, were entitled to deferred underwriting commissions of $0.35 per Unit, or $7,043,750 in the aggregate. The deferred underwriting commissions were expected to become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, dated September 29, 2021, among Barclays, BMO and the Company. On July 14, 2022, Barclays delivered to the Company a notice of resignation of its roles as financial and capital markets advisor to the Company in connection with the Business Combination and waived all rights to fees (including deferred underwriting commissions for services rendered as one of the underwriters in the Company’s IPO) and reimbursement of expenses in connection with the Business Combination. On July 20, 2022, BMO, one of the underwriters in the IPO, delivered to the Company a notice that BMO waived all rights to its portion of the deferred underwriting commissions in connection with the IPO. BMO had no role in connection with the Business Combination. As a result of the Barclays’ resignation letter and BMO’s waiver notice, the Company recorded a gain on derecognition of deferred underwriting fees payable of $326,138 within the accompanying statements of operations.

WARRANT LIABILITIES

WARRANT LIABILITIES	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
WARRANT LIABILITIES
WARRANT LIABILITIES	NOTE 7. WARRANT LIABILITIES The Company accounted for 20,062,500 warrants issued in connection with the Initial Public Offering ( 10,062,500 Public Warrants and 10,000,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant is recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The warrants will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares of Class A Common Stock to holders seeking to exercise their warrants, unless the issuance of the shares of Class A Common Stock issuable upon such warrant exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A Common Stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire, as specified in the Warrant Agreement. If any such registration statement has not been declared effective by the 60 th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A Common Stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the Class A Common Stock under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Redemption of Public Warrants for Cash The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported closing price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Redemption of Warrants for Class A Common Stock The Company may redeem the Public Warrants: ● in whole and not in part; ● at $ 0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined as set out in the Warrant Agreement, based on the redemption date and the “fair market value” of the Class A Common Stock except as otherwise described below; ● if, and only if, the last reported sale price of the Class A Common Stock equals or exceeds $ 10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A Common Stock) as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30 -day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the Warrant Agreement. Additionally, in no event will the Company be required to net cash settle any warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “ Newly Issued Price ”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “ Market Value ”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $ 10.00 per share redemption trigger price described above shall be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.	NOTE 8. WARRANT LIABILITIES The Company accounted for 20,062,500 warrants issued in connection with the Initial Public Offering (10,062,500 Public Warrants and 10,000,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant is recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The warrants will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares of Class A Common Stock to holders seeking to exercise their warrants, unless the issuance of the shares of Class A Common Stock issuable upon such warrant exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A Common Stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire, as specified in the Warrant Agreement. If any such registration statement has not been declared effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A Common Stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the Class A Common Stock under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Redemption of Public Warrants for Cash The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported closing price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Redemption of Warrants for Class A Common Stock The Company may redeem the Public Warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined as set out in the Warrant Agreement, based on the redemption date and the “fair market value” of the Class A Common Stock except as otherwise described below; ● if, and only if, the last reported sale price of the Class A Common Stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A Common Stock) as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30 -day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the Warrant Agreement. Additionally, in no event will the Company be required to net cash settle any warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the holders or such affiliates, as applicable, prior to such issuance) (the “ Newly Issued Price Market Value

CLASS A COMMON STOCK SUBJECT TO

CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION	NOTE 8. CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 380,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 20,125,000 shares of Class A Common Stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets. The Class A Common Stock subject to possible redemption reflected on the balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ ​ (11,247,232) Plus: ​ ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 205,275,000 Accretion of Class A common stock subject to possible redemption amount ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 207,501,604 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,558,841 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 209,060,445 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,291,243 Redemption of Class A common stock on June 29, 2023 ​ ​ (189,038,189) Class A common stock subject to possible redemption at June 30, 2023 ​ $ 21,313,499 ​	NOTE 9. CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 380,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of December 31, 2022 and December 31, 2021, there were 20,125,000 shares of Class A Common Stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheets. The Class A Common Stock subject to possible redemption reflected on the balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ (11,247,232) Plus: ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ $ 205,275,000 Accretion of Class A common stock subject to possible redemption amount, ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ $ 207,501,604 ​

STOCKHOLDER'S DEFICIT

STOCKHOLDER'S DEFICIT	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
STOCKHOLDER'S DEFICIT
STOCKHOLDER'S DEFICIT	NOTE 9. STOCKHOLDER’S DEFICIT Preferred Stock — Class A Common Stock outstanding Class B Common Stock — there were 5,031,250 shares of Class B Common Stock issued and outstanding Simultaneously with the closing of the Initial Public Offering on October 4, 2021, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial business combination on a one-for-one basis , subject to adjustment as provided in the Final Prospectus. Holders of the Class A Common Stock and holders of the Founder Shares will vote together as a single class on all matters submitted to a vote of our stockholders, except as required by law or stock exchange rule; provided that only holders of the Founder Shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination and holders of a majority of the Founder Shares may remove a member of the board of directors for any reason. The Founder Shares will automatically convert into Class A Common Stock at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of shares of Class A Common Stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of (i) the total number of all shares of Class A Common Stock issued in the Offering (including any shares of Class A Common Stock issued pursuant to the underwriters’ over-allotment option) plus (ii) the sum of (i) all shares of Class A Common Stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued in connection with or in relation to the consummation of a Business Combination (including any shares of Class A Common Stock issued pursuant to a forward purchase agreement), excluding any shares of Class A Common Stock or equity-linked securities or rights issued, or to be issued, to any seller in a Business Combination, any Private Placement Warrants issued to the Sponsor, or an affiliate of the Sponsor, or any member of management team upon conversion of Working Capital Loans and any warrants issued pursuant to a forward purchase agreement, minus (ii) the number of shares of Class A Common Stock redeemed in connection with a Business Combination, provided that such conversion of Founder Shares shall never be less than one-to-one. The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.	NOTE 10. STOCKHOLDERS’ DEFICIT Preferred Stock — Class A Common Stock Class B Common Stock — Simultaneously with the closing of the Initial Public Offering on October 4, 2021, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial business combination on a one -for-one basis, subject to adjustment as provided in the Final Prospectus. Holders of the Class A Common Stock and holders of the Founder Shares will vote together as a single class on all matters submitted to a vote of our stockholders, except as required by law or stock exchange rule; provided that only holders of the Founder Shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination and holders of a majority of the Founder Shares may remove a member of the board of directors for any reason. The Founder Shares will automatically convert into Class A Common Stock at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of shares of Class A Common Stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of (i) the total number of all shares of Class A Common Stock issued in the Offering (including any shares of Class A Common Stock issued pursuant to the underwriters’ over-allotment option) plus (ii) the sum of (i) all shares of Class A Common Stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued in connection with or in relation to the consummation of a Business Combination (including any shares of Class A Common Stock issued pursuant to a forward purchase agreement), excluding any shares of Class A Common Stock or equity-linked securities or rights issued, or to be issued, to any seller in a Business Combination, any Private Placement Warrants issued to the Sponsor, or an affiliate of the Sponsor, or any member of management team upon conversion of Working Capital Loans and any warrants issued pursuant to a forward purchase agreement, minus (ii) the number of shares of Class A Common Stock redeemed in connection with a Business Combination, provided that such conversion of Founder Shares shall never be less than one-to-one. The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
FAIR VALUE MEASUREMENT
FAIR VALUE MEASUREMENT	NOTE 10. FAIR VALUE MEASUREMENT The following table presents information about the Company’s assets and liabilities that are measured at fair value at June 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, Description ​ Level ​ 2023 Assets: ​ ​ ​ ​ ​ Investments held in Trust Account, current 1 ​ $ 189,038,189 Investments held in Trust Account, noncurrent ​ 1 ​ $ 22,060,895 Liabilities: ​ ​ ​ ​ ​ Warrant liability – Public Warrants 2 ​ $ 292,819 Warrant liability – Private Placement Warrants 2 ​ $ 291,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000 ​ Warrants The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Balance Sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. The warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. As of June 30, 2023 and December 31, 2022, the fair value of the Private Placement Warrants was the equivalent to that of the Public Warrants as they had substantially the same terms; however, they are not actively traded, as such are listed as a Level 2 in the hierarchy table above.	NOTE 12. FAIR VALUE MEASUREMENT The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description Level 2021 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 205,284,883 Liabilities: ​ ​ Warrant liability – Public Warrants 1 ​ $ 4,943,706 Warrant liability – Private Placement Warrants 2 ​ $ 4,913,000 ​ Warrants The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Balance Sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. The warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. As of December 31, 2022 and December 31, 2021, the fair value of the Private Placement Warrants was the equivalent to that of the Public Warrants as they had substantially the same terms; however, they are not actively traded, as such are listed as a Level 2 in the hierarchy table above. Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. On November 22, 2021, the Public Warrants surpassed the 52-day threshold waiting period to be publicly traded in accordance with the Prospectus filed September 29, 2021. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of December 31, 2021, the Company classified the Public Warrants as Level 1. The estimated value of the Public Warrants and Private Placement Warrants transferred from a Level 3 measurement to a Level 1 measurement and Level 2 measurement, respectively from the initial measurement through December 31, 2021 was $9,856,706 as presented in the changes in fair value of Level 3 warrant liabilities table below. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private ​ ​ Warrant ​ ​ Placement ​ Public ​ Liabilities Fair value as of January 4, 2021 (inception) ​ $ — ​ $ — ​ $ — Initial measurement on October 4, 2021 ​ 5,780,000 ​ 5,816,125 ​ 11,596,125 Change in fair value ​ (867,000) ​ (872,419) ​ (1,739,419) Transfer to Level 1 ​ — ​ (4,943,706) ​ (4,943,706) Transfer to Level 2 ​ (4,913,000) ​ — ​ (4,913,000) Fair value as of December 31, 2021 ​ $ — ​ $ — ​ $ — ​

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated events that have occurred up to the date the unaudited condensed financial statements were issued. Based upon the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed in Note 9 and the following: On July 5, 2023, the Company and Sponsor entered into a subscription agreement (“ Subscription Agreement Investor ● The Investor will make a cash contribution (the “ Capital Contribution ”) to Sponsor in an aggregate amount of $1 million, as follows: (i) an initial tranche of $400,000 , to be paid within two business days of the date of the Subscription Agreement, but no later than July 5, 2023, (ii) a second tranche of $300,000 , to be paid within two business days of the Company and Sponsor entering into a definitive agreement for the Company’s initial business combination, and (iii) a third tranche, subject to written approval of the Company, of $300,000 , to be paid within two business days of the Company submitting both an initial registration statement on Form S-4 with the SEC and amendments to such registration statement in response to comment letters from the SEC. ● The Capital Contribution will in turn be loaned by the Sponsor to the Company to cover working capital expenses (the “ SPAC Loan ”). The SPAC Loan will not accrue interest and will be repaid by the Company upon the closing of the Company’s initial business combination (the “ De-SPAC Closing ”). The Sponsor will pay to the Investor all repayments of the SPAC Loan the Sponsor has received within five business days of the De-SPAC Closing. The Investor may elect at the De-SPAC Closing to receive such payments in cash or shares of Class A common stock of the Company (“ Class A common stock ”) at a rate of one share of Class A common stock for each $10 of the Capital Contribution. ● In consideration for the Capital Contribution, at the De-SPAC Closing the Company will issue to the Investor one share of Class A common stock for each dollar of the Capital Contribution funded by the Investor. The Company agreed that such shares will not be subject to transfer restrictions or any other lock-up provisions, earn outs, or other contingencies and will be registered as part of any registration statement to be filed in connection with the business combination or, if no such registration statement is filed, will be registered as part of the first registration statement to be filed by the Company or the surviving entity following the De-SPAC Closing, which will be filed no later than 30 days after the De-SPAC Closing and be declared effective no later than 90 days after the De-SPAC Closing. ● If the SPAC or Sponsor defaults in its obligations under the Subscription Agreement and such default continues for a period of five business days following written notice, Sponsor agreed to immediately transfer to Investor 100,000 shares of Class A common stock and an additional 100,000 shares of Class A common stock each month thereafter until the default is cured, up to a maximum of 1 million shares of Class A common stock, subject to a 19.9% beneficial ownership limitation set forth in the Subscription Agreement. ● On the De-SPAC Closing, the Sponsor will pay the Investor an amount equal to the reasonable attorney fees incurred by the Investor in connection with the Subscription Agreement not to exceed $5,000 . On July 5, 2023, the Sponsor advanced $400,000 to the Company, of which $180,000 was contributed to the Trust Account for the initial three-month period of the extension. On July 31, 2023, Thomas Granite resigned from his role as Chief Financial Officer position with the Company. On August 3, 2023, the board of directors of the Company appointed Philip Kaplan, the Company’s current Co-Chief Executive Officer and President, as the Principal Financial and Accounting Officer of the Company, succeeding Thomas Granite. On August 7, 2023, the Company and Danam Health, Inc. announced the execution of a Definitive Merger Agreement. Danam Health, Inc. is a health services technology and pharmaceutical distribution company pioneering an ecosystem model designed to empower various stakeholders in the prescription journey and patient medication compliance aspects of healthcare.	NOTE 13. SUBSEQUENT EVENTS The Company evaluated events that have occurred up to the date the financial statements were issued. Based upon the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2023. The interim results for the three months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.	Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and December 31, 2021.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of June 30, 2023 and December 31, 2022, 2,112,027 and 20,125,000 shares of Class A common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.	Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of December 31, 2022 and December 31, 2021, 20,125,000 shares of Class A Common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company had $1,589,736 and $1,316,585 of deferred income tax assets at June 30, 2023 and December 31, 2022, respectively, and a full valuation allowance at the end of each period. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. As of June 30, 2023 and December 31, 2022, income taxes payable of $647,396 and $591,919, respectively, are included in accounts payable and accrued expenses on the Company’s condensed balance sheet.	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. At December 31, 2022 the Company had $1,316,585 of deferred income tax assets and at December 31, 2021, the Company’s deferred income tax assets are deemed to be de minimis. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
Net Income/(Loss) per Common Share	Net Income/(Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income/(Loss) per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income/(Loss) is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. On June 29, 2023, the Company issued an aggregate of 3,412,816 shares of non-redeemable Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (“Founder Share Conversion”). The 3,412,816 shares of non-redeemable Class A common stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B common stock before the Founder Share Conversion (see Note 5). The Company’s basic and diluted income/(loss) per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended Six Months Ended Six Months Ended ​ ​ June 30, 2023 ​ June 30, 2022 ​ June 30, 2023 ​ June 30, 2022 Class A Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class A Common Stock ​ $ 1,115,145 ​ $ 3,614,039 ​ $ 3,141,106 ​ $ 2,610,650 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 19,588,855 ​ ​ 20,125,000 ​ 19,745,490 ​ ​ 20,125,000 Net income/(loss) per share, Class A, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class B common stock ​ $ 278,786 ​ $ 903,510 ​ ​ 785,277 ​ ​ 652,662 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 4,902,371 ​ ​ 5,031,250 ​ 4,938,965 ​ ​ 5,031,250 Net income/(loss) per share, Class B, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13	Net Income per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. The Company’s basic and diluted net income per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the ​ ​ For the period from ​ ​ Year Ended ​ ​ January 4, 2021 to ​ ​ ​ December 31, 2022 ​ ​ December 31, 2021 Class A Common Stock ​ ​ ​ ​ ​ ​ Numerator: Net income allocable to Class A Common Stock ​ $ 2,783,672 ​ $ 162,830 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 20,125,000 ​ 4,947,859 Net income per share, Class A, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ Numerator: Net income allocable to Class B common stock ​ $ 695,918 ​ $ 149,288 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 5,031,250 ​ 4,536,343 Net income per share, Class B, basic and diluted ​ $ 0.14 ​ $ 0.03
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 (including deferred underwriting commissions of an aggregate of approximately $ 7,043,750 which, prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters of the IPO upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively)	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 was charged to temporary equity, and
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ASC 815-40”). Such warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statement of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of any warrants. At that time, the portion of the warrant liabilities related to the warrants will be reclassified to additional paid-in capital.	Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ ASC 815-40
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of company's basic and diluted income/(loss) per share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended Six Months Ended Six Months Ended ​ ​ June 30, 2023 ​ June 30, 2022 ​ June 30, 2023 ​ June 30, 2022 Class A Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class A Common Stock ​ $ 1,115,145 ​ $ 3,614,039 ​ $ 3,141,106 ​ $ 2,610,650 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 19,588,855 ​ ​ 20,125,000 ​ 19,745,490 ​ ​ 20,125,000 Net income/(loss) per share, Class A, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class B common stock ​ $ 278,786 ​ $ 903,510 ​ ​ 785,277 ​ ​ 652,662 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 4,902,371 ​ ​ 5,031,250 ​ 4,938,965 ​ ​ 5,031,250 Net income/(loss) per share, Class B, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the ​ ​ For the period from ​ ​ Year Ended ​ ​ January 4, 2021 to ​ ​ ​ December 31, 2022 ​ ​ December 31, 2021 Class A Common Stock ​ ​ ​ ​ ​ ​ Numerator: Net income allocable to Class A Common Stock ​ $ 2,783,672 ​ $ 162,830 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 20,125,000 ​ 4,947,859 Net income per share, Class A, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ Numerator: Net income allocable to Class B common stock ​ $ 695,918 ​ $ 149,288 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 5,031,250 ​ 4,536,343 Net income per share, Class B, basic and diluted ​ $ 0.14 ​ $ 0.03

CLASS A COMMON STOCK SUBJECT _2

CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Schedule of reconciliation of Class A common stock subject to possible redemption	​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ ​ (11,247,232) Plus: ​ ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 205,275,000 Accretion of Class A common stock subject to possible redemption amount ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 207,501,604 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,558,841 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 209,060,445 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,291,243 Redemption of Class A common stock on June 29, 2023 ​ ​ (189,038,189) Class A common stock subject to possible redemption at June 30, 2023 ​ $ 21,313,499	​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ (11,247,232) Plus: ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ $ 205,275,000 Accretion of Class A common stock subject to possible redemption amount, ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ $ 207,501,604

FAIR VALUE MEASUREMENT (Tables)

FAIR VALUE MEASUREMENT (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
FAIR VALUE MEASUREMENT
Schedule of company's assets and liabilities that are measured at fair value	​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, Description ​ Level ​ 2023 Assets: ​ ​ ​ ​ ​ Investments held in Trust Account, current 1 ​ $ 189,038,189 Investments held in Trust Account, noncurrent ​ 1 ​ $ 22,060,895 Liabilities: ​ ​ ​ ​ ​ Warrant liability – Public Warrants 2 ​ $ 292,819 Warrant liability – Private Placement Warrants 2 ​ $ 291,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000	​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description Level 2021 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 205,284,883 Liabilities: ​ ​ Warrant liability – Public Warrants 1 ​ $ 4,943,706 Warrant liability – Private Placement Warrants 2 ​ $ 4,913,000
Schedule of change in the fair value of the warrant liabilities		​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private ​ ​ Warrant ​ ​ Placement ​ Public ​ Liabilities Fair value as of January 4, 2021 (inception) ​ $ — ​ $ — ​ $ — Initial measurement on October 4, 2021 ​ 5,780,000 ​ 5,816,125 ​ 11,596,125 Change in fair value ​ (867,000) ​ (872,419) ​ (1,739,419) Transfer to Level 1 ​ — ​ (4,943,706) ​ (4,943,706) Transfer to Level 2 ​ (4,913,000) ​ — ​ (4,913,000) Fair value as of December 31, 2021 ​ $ — ​ $ — ​ $ —

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)									3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 29, 2023 USD ($) item $ / shares	Dec. 14, 2022	Sep. 02, 2022 USD ($) shares	Mar. 28, 2022 USD ($) $ / shares shares	Oct. 04, 2021 USD ($) $ / shares shares	Mar. 16, 2021 $ / shares shares	Jan. 05, 2021 USD ($) $ / shares shares	Jan. 04, 2021 item	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Jul. 20, 2022 USD ($)	Jul. 14, 2022 USD ($)	Mar. 28, 2022 EUR (€)
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Condition for future business combination number of businesses minimum | item								1
Aggregate purchase price													$ 25,000
Purchase price, per unit | $ / shares										$ 10		$ 10
Sale of units, net of underwriting discounts (in shares) | shares										13,020,000		13,020,000
Number of shares no longer subject to forfeiture | shares										656,250		656,250
Proceeds from issuance of units										$ 130,200,000		$ 130,200,000
Proceeds from issuance of private placement warrants													10,000,000
Underwriting commissions														$ 2,465,312	$ 4,578,438
Deferred underwriting fee payable													6,693,750
Other offering costs										$ 13,158,021		13,158,021
Adjustment to stockholders' deficit												6,717,612
Gain from recognition of deferred underwriting fee payable									$ 326,138		$ 326,138	$ 326,138
Payments for investment of cash in trust account													205,275,000
Condition for future business combination use of proceeds percentage										80		80
Condition for future business combination threshold percentage ownership										50		50
Minimum net tangible assets upon consummation of business combination										$ 5,000,001
Maximum allowed dissolution expenses										$ 100,000		$ 100,000
Obligation to redeem public shares if entity does not complete a business combination (as a percent)										100%		100%
Cash										$ 51,409		$ 160,940	953,329
Working capital deficit										6,999,802		5,942,600
Issuance costs													548,505
Working capital loans										0		0
Term for which the period to complete Initial Business Combination shall be extended each time	1 month
Number of times the period to complete Initial Business Combination can be extended | item	6
Maximum extension term to complete Initial Business Combination	9 months
Investments held in Trust Account										22,060,895		208,244,129	$ 205,284,883
Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount in excess of gross proceeds				$ 100,000,000
Closing share valuation			$ 500,000,000
Minimum closing cash consideration after transaction expenses and redemptions				$ 12,500,000
Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares						1,618,434
Aggregate purchase price										$ 13,796,426		$ 13,796,426
Sponsor forfeited common stock | shares						1,618,434
Purchase price | $ / shares						$ 0.006				$ 8.54		$ 8.54
Common Stock, Conversion Basis										The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial business combination on a one-for-one basis
Share Price | $ / shares						$ 0.006				$ 8.54		$ 8.54
Common stock, conversion basis												1
PubCo | Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Minimum percentage of redemption on outstanding shares of common stock for issuing additional cash consideration				85%
Maximum percentage of redemption on outstanding shares of common stock for issuing deferred cash consideration				85%
Deferred share consideration | shares				12,254,902
Earnout consideration | shares				10,000,000
Novibet
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Shares converted | shares				1
Komisium Limited | Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Minimum percentage of redemption on outstanding shares of common stock for issuing additional cash consideration			85%
Maximum percentage of redemption on outstanding shares of common stock for issuing deferred cash consideration			85%
Maximum percentage pf shares to be transferred		10%		30%
Maximum amount of divided to be paid | €																€ 3,579,625
Komisium Limited | PubCo | Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Closing cash consideration				$ 50,000,000
Closing share consideration				$ 500,000,000
Price per share | $ / shares				$ 10.20
Initial Share Premium				$ 598,000
Additional Closing Share Consideration | shares				12,254,902
Deferred share consideration | shares				12,254,902
Number of shares to be retained | shares				65,000
Number of shares issuable | shares			12,254,902
Class B common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares						5,031,250	25,000
Common stock, par value (in dollars per share) | $ / shares										0.0001		$ 0.0001	$ 0.0001
Aggregate purchase price							$ 25,000
Purchase price, per unit | $ / shares							$ 0.006
Number of shares no longer subject to forfeiture | shares						5,031,250
Class B common stock | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sponsor forfeited common stock | shares					1,618,434
Purchase price | $ / shares					$ 0.006
Share Price | $ / shares					0.006
Class A common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001					$ 0.0001		0.0001	$ 0.0001
Number of shares in a unit | shares					1
Number of shares redeemed | shares										18,012,973
Redemption price per share | $ / shares										$ 10.49
Redemption amount										$ 189,000,000
PubCo Ordinary Share
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Shares converted in to the rights of the holder | shares				1
Conversion of shares exercisable | shares				1
Anchor Investor Warrants | Class B common stock | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares					1,618,434
Purchase price | $ / shares					$ 0.006
Share Price | $ / shares					$ 0.006
Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price | $ / shares										$ 9.20		9.20
Share Price | $ / shares										9.20		$ 9.20
Public Warrants | Class A common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of warrants in a unit | shares					0.5
Sponsor
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price | $ / shares	$ 0.105									$ 0.035
Issuance costs										$ 25,000		$ 25,000
Investments held in Trust Account	$ 180,000									$ 60,000
Share Price | $ / shares	$ 0.105									$ 0.035
Sponsor | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares					1,618,434	1,618,434	4,312,500
Aggregate purchase price							$ 25,000
Sponsor | Class B common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares							4,312,500
Common stock, par value (in dollars per share) | $ / shares							$ 0.0001
Sponsor forfeited common stock | shares					1,618,434
Sponsor | Class A common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares							4,312,500
Sponsor | Class A common stock | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Founder share conversion ratio										1
Sponsor | Anchor Investor Warrants | Class B common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares) | shares					1,618,434
Purchase price | $ / shares					$ 0.006
Share Price | $ / shares					0.006
Initial Public Offering
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price, per unit | $ / shares					$ 10.20
Sale of units, net of underwriting discounts (in shares) | shares					20,125,000
Proceeds from issuance initial public offering					$ 201,250,000
Transaction costs					25,559,771
Underwriting fees					3,825,000
Underwriting commissions					7,043,750					$ 7,043,750		7,043,750
Other offering costs					894,595					$ 1,154,518		$ 1,154,518
Offering cost related to founder shares					13,796,426
Offering cost related to equity					13,158,021
Offering cost					638,405
Payments for investment of cash in trust account					$ 205,275,000
Threshold percentage of public shares subject to redemption without company's prior written consent										15%		15%
Issuance costs										$ 25,559,771		$ 25,559,771
Initial Public Offering | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares) | shares						20,125,000
Percentage of founder shares issued and outstanding						20%
Initial Public Offering | Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares in a unit | shares					1
Number of warrants in a unit | shares					0.50
Number of shares per warrant | shares					1
Initial Public Offering | Sponsor
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price, per unit | $ / shares										$ 10		$ 10
Sale of units, net of underwriting discounts (in shares) | shares										2,732,500		2,732,500
Proceeds from issuance of units										$ 27,325,000		$ 27,325,000
Private Placement | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares) | shares					8,000,000					8,000,000
Price of warrant | $ / shares					$ 1					$ 1
Proceeds from issuance of private placement warrants					$ 8,000,000					$ 8,000,000
Private Placement | Anchor Investor Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares) | shares					2,000,000
Price of warrant | $ / shares					$ 1					$ 1
Proceeds from issuance of private placement warrants					$ 2,000,000
Private Placement | Sponsor | Anchor Investor Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares) | shares										2,000,000		2,000,000
Over-allotment option
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price, per unit | $ / shares					$ 10
Sale of units, net of underwriting discounts (in shares) | shares					2,625,000
Over-allotment option | Anchor Investor Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Proceeds from issuance of private placement warrants					$ 2,000,000					$ 2,000,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)		3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 29, 2023	Sep. 30, 2022	Jun. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Jul. 20, 2022	Jul. 14, 2022	Oct. 04, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents			$ 0		$ 0	$ 0	$ 0
Minimum net tangible assets upon consummation of business combination			5,000,001
Deferred tax asset			1,589,736		1,316,585	272,783	272,783
Unrecognized tax benefits			0		0	0	0
Unrecognized tax benefits accrued for interest and penalties			0		0	0	0
Offering costs						$ 548,505
Underwriting commissions								$ 2,465,312	$ 4,578,438
Adjustment to stockholders' deficit					6,717,612
Gain from recognition of deferred underwriting fee payable		$ 326,138		$ 326,138	326,138
Offering costs charged to temporary equity			10,897,232		10,897,232		$ (11,247,232)
Other offering costs			13,158,021		13,158,021
Additional deferred underwriting fees					350,000
Income taxes payable			647,396		591,919
Initial Public Offering
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Offering costs			25,559,771		25,559,771
Underwriting commissions			7,043,750		7,043,750					$ 7,043,750
Other offering costs			1,154,518		1,154,518					$ 894,595
Sponsor
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Offering costs			$ 25,000		$ 25,000
Class A common stock | Founder Shares | Sponsor
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares issued upon conversion of Founder Shares	3,412,816
Class A common stock subject to redemption
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Ordinary shares, shares subject to possible redemption			20,125,000		20,125,000	20,125,000	20,125,000
Offering costs charged to temporary equity							$ (11,247,232)
Class A common stock subject to redemption | Initial Public Offering
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Ordinary shares, shares subject to possible redemption			20,125,000		20,125,000
Class A common stock subject to possible redemption
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Ordinary shares, shares subject to possible redemption			2,112,027		20,125,000	20,125,000	20,125,000
Class B common stock | Founder Shares | Sponsor
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares issued upon conversion of Founder Shares	3,412,816

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) per Share of Common Stock (Details) - USD ($)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Class A common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Numerator: Net income allocable to Class A Common Stock	$ 1,115,145		$ 3,614,039	$ 3,141,106	$ 2,610,650		$ 2,783,672	$ 162,830
Weighted average shares of common stock outstanding, basic	19,588,855	20,125,000	20,125,000	19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Weighted average shares of common stock outstanding, diluted	19,588,855	20,125,000	20,125,000	19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Basic net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Class B common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Numerator: Net income allocable to Class A Common Stock	$ 278,786		$ 903,510	$ 785,277	$ 652,662		$ 695,918	$ 149,288
Weighted average shares of common stock outstanding, basic	4,902,371	5,031,250	5,031,250	4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Weighted average shares of common stock outstanding, diluted	4,902,371	5,031,250	5,031,250	4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Basic net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - $ / shares		6 Months Ended	12 Months Ended
	Oct. 04, 2021	Jun. 30, 2023	Dec. 31, 2022
INITIAL PUBLIC OFFERING
Number of units sold		13,020,000	13,020,000
Purchase price, per unit		$ 10	$ 10
Initial Public Offering
INITIAL PUBLIC OFFERING
Number of units sold	20,125,000
Purchase price, per unit	$ 10.20
Initial Public Offering | Public Warrants
INITIAL PUBLIC OFFERING
Number of shares in a unit	1
Number of warrants in a unit	0.50
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Over-allotment option
INITIAL PUBLIC OFFERING
Number of units sold	2,625,000
Purchase price, per unit	$ 10

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		6 Months Ended	12 Months Ended
	Oct. 04, 2021	Jun. 30, 2023	Dec. 31, 2021
PRIVATE PLACEMENT
Aggregate purchase price			$ 10,000,000
Private Placement | Private Placement Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	8,000,000	8,000,000
Price of warrants	$ 1	$ 1
Aggregate purchase price	$ 8,000,000	$ 8,000,000
Private Placement | Anchor Investor Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	2,000,000
Price of warrants	$ 1	$ 1
Aggregate purchase price	$ 2,000,000

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)					6 Months Ended	12 Months Ended
	Jun. 29, 2023 $ / shares shares	Oct. 04, 2021 $ / shares shares	Mar. 16, 2021 $ / shares shares	Jan. 05, 2021 USD ($) shares	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) D $ / shares shares	Dec. 31, 2021 USD ($) shares
RELATED PARTY TRANSACTIONS
Aggregate purchase price | $							$ 25,000
Class B common stock
RELATED PARTY TRANSACTIONS
Stock sold			5,031,250	25,000
Aggregate purchase price | $				$ 25,000
Common shares, shares outstanding (in shares)	1,618,434				1,618,434	5,031,250	5,031,250
Class A common stock
RELATED PARTY TRANSACTIONS
Common shares, shares outstanding (in shares)					3,412,816	0
Sponsor
RELATED PARTY TRANSACTIONS
Purchase price | $ / shares	$ 0.105				$ 0.035
Sponsor | Class B common stock
RELATED PARTY TRANSACTIONS
Stock sold				4,312,500
Sponsor forfeited common stock		1,618,434
Sponsor | Class A common stock
RELATED PARTY TRANSACTIONS
Stock sold				4,312,500
Founder Shares
RELATED PARTY TRANSACTIONS
Stock sold			1,618,434
Aggregate purchase price | $					$ 13,796,426	$ 13,796,426
Sponsor forfeited common stock			1,618,434
Purchase price | $ / shares			$ 0.006		$ 8.54	$ 8.54
Founder Shares | Class B common stock
RELATED PARTY TRANSACTIONS
Sponsor forfeited common stock		1,618,434
Purchase price | $ / shares		$ 0.006
Founder Shares | Sponsor
RELATED PARTY TRANSACTIONS
Stock sold		1,618,434	1,618,434	4,312,500
Aggregate purchase price | $				$ 25,000
Common shares, shares outstanding (in shares)			5,031,250
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares					$ 12	$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination					20	20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination					30	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences					150 days	150 days
Founder Shares | Sponsor | Class B common stock
RELATED PARTY TRANSACTIONS
Number of shares issued upon conversion of Founder Shares	3,412,816
Founder Shares | Sponsor | Class A common stock
RELATED PARTY TRANSACTIONS
Number of shares issued upon conversion of Founder Shares	3,412,816

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)			3 Months Ended	6 Months Ended		12 Months Ended
	Oct. 04, 2021	Sep. 30, 2021	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Jan. 05, 2021
RELATED PARTY TRANSACTIONS
Repayment of promissory note - related party								$ 162,892
Promissory Note with Related Party
RELATED PARTY TRANSACTIONS
Maximum borrowing capacity of related party promissory note									$ 300,000
Repayment of promissory note - related party	$ 162,892					$ 162,892
Administrative Support Agreement
RELATED PARTY TRANSACTIONS
Expenses per month		$ 10,000
Expenses incurred			$ 30,000	$ 60,000	$ 30,000	120,000		$ 30,000
Expenses paid			20,000	20,000	$ 60,000
Related Party Loans | Working capital loans warrant
RELATED PARTY TRANSACTIONS
Loan conversion agreement warrant			$ 1,500,000	$ 1,500,000		$ 1,500,000
Price of warrant			$ 1	$ 1		$ 1
Expenses incurred				$ 0		$ 0	$ 0

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) item $ / shares	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) item $ / shares
COMMITMENTS AND CONTINGENCIES
Maximum number of demands for registration of securities | item		3		3
Deferred fee per unit | $ / shares		$ 0.35		$ 0.35
Aggregate deferred underwriting fee payable		$ 7,043,750		$ 7,043,750
Gain from recognition of deferred underwriting fee payable	$ 326,138		$ 326,138	326,138
Derecognition of deferred underwriting fee payable allocated to Class A common stock				6,717,612
Class A common stock subject to redemption
COMMITMENTS AND CONTINGENCIES
Derecognition of deferred underwriting fee payable allocated to Class A common stock				$ 6,717,612

WARRANT LIABILITIES (Details)

WARRANT LIABILITIES (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 D $ / shares shares	Dec. 31, 2022 D $ / shares shares
WARRANT LIABILITIES
Threshold period for filling registration statement after business combination	15 days	15 days
Period of time within which registration statement is expected to become effective	60 days	60 days
Stock price trigger for redemption of public warrants	$ 9.20	$ 9.20
Adjustment of exercise price of warrants based on market value (as a percent)	115%	115%
Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00
WARRANT LIABILITIES
Stock price trigger for redemption of public warrants	$ 18	$ 18
Percentage of adjustment of redemption price of stock based on market value.	180%	180%
Redemption of Public Warrants for Cash
WARRANT LIABILITIES
Redemption price per public warrant (in dollars per share)	$ 0.01	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days	30 days
Stock price trigger for redemption of public warrants	$ 18	$ 18
Threshold trading days for redemption of public warrants	20 days	20 days
Threshold consecutive trading days for redemption of public warrants | D	30	30
Threshold number of business days before sending notice of redemption to warrant holders | D	3	3
Redemption of Warrants for Class A Common Stock
WARRANT LIABILITIES
Redemption price per public warrant (in dollars per share)	$ 0.10	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days	30 days
Stock price trigger for redemption of public warrants	$ 10	$ 10
Threshold consecutive trading days for redemption of public warrants | D	30	30
Warrants
WARRANT LIABILITIES
Warrants outstanding | shares	20,062,500	20,062,500
Warrants expiration term	5 years	5 years
Public Warrants
WARRANT LIABILITIES
Warrants outstanding | shares	10,062,500	10,062,500
Warrants exercisable term from the completion of business combination	30 days	30 days
Warrants expiration term	5 years	5 years
Warrants exercisable for cash | shares		0
Threshold consecutive trading days for redemption of public warrants | D	20	20
Share Price	$ 9.20	$ 9.20
Percentage of gross proceeds on total equity proceeds	60%	60%
Private Placement Warrants
WARRANT LIABILITIES
Warrants outstanding | shares	10,000,000	10,000,000

CLASS A COMMON STOCK SUBJECT _3

CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)	3 Months Ended				6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($) Vote $ / shares shares	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) Vote $ / shares shares	Dec. 31, 2022 USD ($) Vote $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Oct. 04, 2021 $ / shares
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Offering Costs allocated to Class A common stock subject to possible redemption					$ 10,897,232	$ 10,897,232		$ (11,247,232)
Additional deferred underwriting fees						350,000
Accretion of Class A common stock subject to possible redemption amount	$ 1,291,243	$ 1,558,841	$ (5,452,319)	$ 350,000		(4,141,008)	$ 20,738,357
Derecognition of deferred underwriting fee payable allocated to Class A common stock						$ 6,717,612
Redemption of Class A common stock	$ 189,038,189				$ 189,038,189
Class A common stock subject to redemption
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Temporary equity, shares authorized | shares	380,000,000				380,000,000
Ordinary shares, shares subject to possible redemption | shares	20,125,000				20,125,000	20,125,000	20,125,000	20,125,000
Gross proceeds from Initial Public Offering								$ 201,250,000
Fair Value of Public Warrants at Issuance								(5,816,125)
Offering Costs allocated to Class A common stock subject to possible redemption								(11,247,232)
Accretion of Class A common stock subject to possible redemption amount	$ 1,291,243	1,558,841				$ (4,141,008)		21,088,357
Derecognition of deferred underwriting fee payable allocated to Class A common stock						6,717,612
Additional offering cost related to deferred underwriting fees						(350,000)
Redemption of Class A common stock	(189,038,189)				$ (189,038,189)
Class A common stock subject to possible redemption	$ 21,313,499	$ 209,060,445			$ 21,313,499	$ 207,501,604	$ 205,275,000	$ 205,275,000
Class A common stock
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Temporary equity, shares authorized | shares						380,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001				$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Temporary equity, par value | $ / shares						$ 0.0001
Common shares, votes per share | Vote	1				1	1

STOCKHOLDER'S DEFICIT - Preferr

STOCKHOLDER'S DEFICIT - Preferred Stock Shares (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
STOCKHOLDER'S DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0	0
Preferred shares, shares outstanding	0	0	0

STOCKHOLDER'S DEFICIT - Common

STOCKHOLDER'S DEFICIT - Common Stock Shares (Details) $ / shares in Units, $ in Millions		6 Months Ended
	Jun. 29, 2023 shares	Jun. 30, 2023 USD ($) Vote $ / shares shares	Dec. 31, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares	Oct. 04, 2021 $ / shares	Mar. 16, 2021 shares	Jan. 05, 2021 $ / shares
Sponsor | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares outstanding (in shares)						5,031,250
Class A common stock
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares authorized (in shares)		380,000,000	380,000,000	380,000,000
Common shares, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote		1	1
Common shares, shares issued (in shares)		3,412,816	0
Common shares, shares outstanding (in shares)		3,412,816	0
Number of shares redeemed		18,012,973
Redemption price per share | $ / shares		$ 10.49
Redemption amount | $		$ 189
Class A common stock | Sponsor | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Number of shares issued upon conversion of Founder Shares	3,412,816
Conversion of Stock, Shares Issued	3,412,816
Common Stock, Conversion Ratio		1
Class A common stock not subject to possible redemption
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares issued (in shares)			0	0
Common shares, shares outstanding (in shares)			0	0
Class A common stock subject to possible redemption
STOCKHOLDER'S EQUITY/(DEFICIT)
Common stock subject to possible redemption		2,112,027	20,125,000	20,125,000
Redemption price per share | $ / shares		$ 10.09	$ 10.31	$ 10.20
Class B common stock
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares authorized (in shares)		20,000,000	20,000,000	20,000,000
Common shares, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote		1	1
Common shares, shares issued (in shares)		1,618,434	5,031,250	5,031,250
Common shares, shares outstanding (in shares)	1,618,434	1,618,434	5,031,250	5,031,250
Class B common stock | Sponsor
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, par value (in dollars per share) | $ / shares							$ 0.0001
Class B common stock | Sponsor | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Number of shares issued upon conversion of Founder Shares	3,412,816
Conversion of Stock, Shares Issued	3,412,816

STOCKHOLDER'S DEFICIT (Details)

STOCKHOLDER'S DEFICIT (Details)				6 Months Ended	12 Months Ended
	Oct. 04, 2021 $ / shares shares	Mar. 16, 2021 $ / shares shares	Jan. 05, 2021 shares	Jun. 30, 2023 $ / shares	Dec. 31, 2022 $ / shares
Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Shares subject to forfeiture		1,618,434
Stock sold		1,618,434
Share Price | $ / shares		$ 0.006		$ 8.54	$ 8.54
Common stock, conversion basis					1
Common stock conversion basis				The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial business combination on a one-for-one basis
Class B common stock
STOCKHOLDER'S EQUITY/(DEFICIT)
Stock sold		5,031,250	25,000
Ratio to be applied to the stock in the conversion				25	25
Class B common stock | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Shares subject to forfeiture	1,618,434
Share Price | $ / shares	$ 0.006
Class B common stock | Anchor Investor Warrants | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Stock sold	1,618,434
Share Price | $ / shares	$ 0.006

FAIR VALUE MEASUREMENT - Compan

FAIR VALUE MEASUREMENT - Company's assets and liabilities that are measured at fair value (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Assets:
Investments held in Trust Account, current	$ 189,038,189
Investments held in Trust Account	22,060,895	$ 208,244,129	$ 205,284,883
Liabilities:
Warrant liability			9,856,706
Level 1
Assets:
Investments held in Trust Account, current	189,038,189
Investments held in Trust Account	22,060,895	208,244,129	205,284,883
Level 1 | Public Warrants
Liabilities:
Warrant liability		1,360,450	4,943,706
Level 2 | Public Warrants
Liabilities:
Warrant liability	292,819
Level 2 | Private Placement Warrants
Liabilities:
Warrant liability	$ 291,000	$ 1,352,000	$ 4,913,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)			6 Months Ended	12 Months Ended
	Jul. 05, 2023 USD ($) $ / shares shares	Jun. 29, 2023 USD ($) shares	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2022 USD ($) shares	Mar. 16, 2021 shares
Subsequent Event
Proceeds from Related Party Debt | $				$ 100,000
Balance in the Company's Trust Account | $			$ 22,060,895	$ 205,284,883	$ 208,244,129
Class A common stock
Subsequent Event
Number of shares redeemed | shares			18,012,973
Redemption price per share | $ / shares			$ 10.49
Redemption amount | $			$ 189,000,000
Common stock, shares issued | shares			3,412,816		0
Common stock, shares outstanding | shares			3,412,816		0
Class B common stock
Subsequent Event
Common stock, shares issued | shares			1,618,434	5,031,250	5,031,250
Common stock, shares outstanding | shares		1,618,434	1,618,434	5,031,250	5,031,250
Sponsor
Subsequent Event
Balance in the Company's Trust Account | $		$ 180,000	$ 60,000
Sponsor | Founder Shares
Subsequent Event
Common stock, shares outstanding | shares						5,031,250
Sponsor | Founder Shares | Class A common stock
Subsequent Event
Number of shares issued upon conversion of Founder Shares | shares		3,412,816
Founder share conversion ratio			1
Sponsor | Founder Shares | Class B common stock
Subsequent Event
Number of shares issued upon conversion of Founder Shares | shares		3,412,816
Subsequent event
Subsequent Event
Contributed to trust account | $	$ 180,000
Subsequent event | SPAC Loan
Subsequent Event
Percentage of beneficial ownership limitation	19.90%
Subsequent event | Sponsor
Subsequent Event
Proceeds from Related Party Debt | $	$ 400,000
Subsequent event | Sponsor | Class A common stock
Subsequent Event
Number of shares for each $10 of the Capital Contribution, that the investor may elect to receive back the loan in shares | $ / shares	$ 1
Number of shares to be issued for each dollar of the Capital Contribution made by the investor | shares	10
Subsequent event | Sponsor | SPAC Loan
Subsequent Event
Capital contribution to be made by Investor | $	$ 1,000,000
Capital contribution to be made by Investor, Initial Tranche | $	400,000,000
Capital contribution to be made by Investor, Second Tranche | $	300,000,000
Capital contribution to be made by Investor, Third Tranche | $	300,000,000
Number of business days within which the Third Tranche of capital contribution is to be made by investor | $	2,000
Maximum attorney fees agreed to be paid to investor | $	$ 5,000
Subsequent event | Sponsor | SPAC Loan | Class A common stock
Subsequent Event
Number of shares agreed to issue to investor upon default | shares	100,000
Number of shares agreed to issue to investor upon default, each month thereafter until the default is cured | shares	100,000
Subsequent event | Sponsor | SPAC Loan | Class A common stock | Maximum
Subsequent Event
Number of shares agreed to issue to investor upon default | shares	1

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 03, 2021
Current assets
Cash	$ 51,409		$ 160,940				$ 953,329
Prepaid expenses	35,000		106,495				450,708
Total Current Assets	189,124,598		267,435				1,404,037
Investments held in Trust Account	22,060,895		208,244,129				205,284,883
Total Assets	211,185,493		208,511,564				206,688,920
Current liabilities
Accounts payable and accrued expenses	7,086,211		6,210,035				396,587
Total Current Liabilities	196,124,400		6,210,035				396,587
Derivative warrant liabilities	583,819		2,712,450				9,856,706
Deferred underwriting fee payable							6,693,750
Total Liabilities	196,708,219		8,922,485				16,947,043
Commitments and Contingencies
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Accumulated deficit	(6,836,728)		(7,913,028)				(15,533,626)
Total Stockholders' Deficit	(6,836,225)	$ (6,938,913)	(7,912,525)	$ (6,775,298)	$ (12,619,810)	$ (16,787,359)	(15,533,123)	$ 0
Total Liabilities and Stockholders' Deficit	211,185,493		208,511,564				206,688,920
Class A common stock
Stockholders' Deficit
Common stock	341
Class A common stock subject to possible redemption
Current liabilities
Class A common stock; 20,125,000 shares subject to possible redemption at $10.45 and $10.31 per share at June 30, 2023 and December 31, 2022, respectively	21,313,499		207,501,604				205,275,000
Class A common stock not subject to possible redemption
Stockholders' Deficit
Common stock			0				0
Class B common stock
Stockholders' Deficit
Common stock	$ 162		$ 503				$ 503

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Jun. 29, 2023	Dec. 31, 2022	Dec. 31, 2021	Oct. 04, 2021
Preferred stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000		1,000,000	1,000,000
Preferred stock, shares issued	0		0	0
Preferred stock, shares outstanding	0		0	0
Class A common stock
Common stock, redemption value per share	$ 10.49
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	380,000,000		380,000,000	380,000,000
Common stock, shares issued	3,412,816		0
Common stock, shares outstanding	3,412,816		0
Class A common stock subject to possible redemption
Common stock subject to possible redemption	2,112,027		20,125,000	20,125,000
Common stock, redemption value per share	$ 10.09		$ 10.31	$ 10.20
Class A common stock not subject to possible redemption
Common stock, shares issued			0	0
Common stock, shares outstanding			0	0
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000		20,000,000	20,000,000
Common stock, shares issued	1,618,434		5,031,250	5,031,250
Common stock, shares outstanding	1,618,434	1,618,434	5,031,250	5,031,250

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended					6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Formation and general and administrative expenses	$ 227,545			$ 781,914		$ 812,684	$ 5,054,348		$ 6,469,453	$ 282,666
Loss from operations	(227,545)			(781,914)		(812,684)	(5,054,348)		(6,469,453)	(282,666)
Other income (expense)
Interest earned on investments held in trust account	1,807,023			231,675		3,835,611	266,579		3,070,568	9,883
Gain from recognition of deferred underwriting fee payable			$ 326,138					$ 326,138	326,138
Transaction costs allocated to warrant liabilities										(1,154,518)
Change in fair value of warrant liabilities	619,931			5,067,788		2,128,631	8,051,082		7,144,256	1,739,419
Total other income	2,426,954		1,114,342	5,299,463		5,964,242	8,317,661	9,432,004	10,540,962	594,784
Income before provision for income taxes	2,199,409			4,517,549		5,151,558	3,263,313		4,071,509	312,118
Provision for income taxes	805,478					1,225,175			591,919
Net income	$ 1,393,931	$ 2,532,453	$ 392,193	$ 4,517,549	$ (1,254,236)	$ 3,926,383	$ 3,263,313	$ 3,655,506	$ 3,479,590	$ 312,118
Class A common stock
Other income (expense)
Weighted average shares of common stock outstanding, basic	19,588,855		20,125,000	20,125,000		19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Weighted average shares of common stock outstanding, diluted	19,588,855		20,125,000	20,125,000		19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Basic net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Class B common stock
Other income (expense)
Weighted average shares of common stock outstanding, basic	4,902,371		5,031,250	5,031,250		4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Weighted average shares of common stock outstanding, diluted	4,902,371		5,031,250	5,031,250		4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Basic net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03

STATEMENTS OF CHANGES IN STOCKH

STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Class B common stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Jan. 03, 2021	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Jan. 03, 2021	0
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount		(4,892,613)	(15,845,744)	(20,738,357)
Issuance of Class B common stock to Sponsor	$ 503	24,497		25,000
Issuance of Class B common stock to Sponsor (in shares)	5,031,250
Forfeiture of Class B common stock from Sponsor	$ (162)	162
Forfeiture of Class B common stock from Sponsor, (in shares)	(1,618,434)
Sale of Class B common stock to Institutional Anchor Investors	$ 162	647,954		648,116
Sale of Class B common stock to Institutional Anchor Investors, (in shares)	1,618,434
Excess cash received over the fair value of the private warrants		4,220,000		4,220,000
Net income			312,118	312,118
Balance at the end at Dec. 31, 2021	$ 503	0	(15,533,626)	(15,533,123)
Balance at the end (in shares) at Dec. 31, 2021	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income			(1,254,236)	(1,254,236)
Balance at the end at Mar. 31, 2022	$ 503		(16,787,862)	(16,787,359)
Balance at the end (in shares) at Mar. 31, 2022	5,031,250
Balance at the beginning at Dec. 31, 2021	$ 503	0	(15,533,626)	(15,533,123)
Balance at the beginning (in shares) at Dec. 31, 2021	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income				3,263,313
Balance at the end at Jun. 30, 2022	$ 503		(12,620,313)	(12,619,810)
Balance at the end (in shares) at Jun. 30, 2022	5,031,250
Balance at the beginning at Dec. 31, 2021	$ 503	0	(15,533,626)	(15,533,123)
Balance at the beginning (in shares) at Dec. 31, 2021	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income				3,655,506
Balance at the end at Sep. 30, 2022			(6,775,801)	(6,775,298)
Balance at the beginning at Dec. 31, 2021	$ 503	$ 0	(15,533,626)	(15,533,123)
Balance at the beginning (in shares) at Dec. 31, 2021	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			4,141,008	4,141,008
Net income			3,479,590	3,479,590
Balance at the end at Dec. 31, 2022	$ 503		(7,913,028)	(7,912,525)
Balance at the end (in shares) at Dec. 31, 2022	5,031,250
Balance at the beginning at Mar. 31, 2022	$ 503		(16,787,862)	(16,787,359)
Balance at the beginning (in shares) at Mar. 31, 2022	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			(350,000)	(350,000)
Net income			4,517,549	4,517,549
Balance at the end at Jun. 30, 2022	$ 503		(12,620,313)	(12,619,810)
Balance at the end (in shares) at Jun. 30, 2022	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			5,452,319	5,452,319
Net income			392,193	392,193
Balance at the end at Sep. 30, 2022			(6,775,801)	(6,775,298)
Balance at the beginning at Dec. 31, 2022	$ 503		(7,913,028)	(7,912,525)
Balance at the beginning (in shares) at Dec. 31, 2022	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			(1,558,841)	(1,558,841)
Net income			2,532,453	2,532,453
Balance at the end at Mar. 31, 2023	$ 503		(6,939,416)	(6,938,913)
Balance at the end (in shares) at Mar. 31, 2023	5,031,250
Balance at the beginning at Dec. 31, 2022	$ 503		(7,913,028)	(7,912,525)
Balance at the beginning (in shares) at Dec. 31, 2022	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income				3,926,383
Balance at the end at Jun. 30, 2023	$ 162		(6,836,728)	(6,836,225)
Balance at the end (in shares) at Jun. 30, 2023	1,618,434
Balance at the beginning at Mar. 31, 2023	$ 503		(6,939,416)	(6,938,913)
Balance at the beginning (in shares) at Mar. 31, 2023	5,031,250
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			(1,291,243)	(1,291,243)
Net income			1,393,931	1,393,931
Balance at the end at Jun. 30, 2023	$ 162		$ (6,836,728)	$ (6,836,225)
Balance at the end (in shares) at Jun. 30, 2023	1,618,434

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS	12 Months Ended
	Dec. 31, 2021 USD ($)
Cash flows from operating activities:
Net income	$ 312,118
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on investments held in trust account	(9,883)
Change in fair value of warrant liabilities	(1,739,419)
Transaction costs allocated to warrant liabilities	1,154,518
Formation and operating costs paid by Sponsor in exchange for issuance of Class B Common Stock	1,596
Formation and operating costs paid by promissory note	498
Adjustments to operating assets and liabilities:
Decrease (Increase) in prepaid expenses	(451,206)
Increase in accounts payable and accrued expenses	136,794
Net cash used in operating activities	(594,984)
Cash flows from investing activities:
Investment of cash in Trust Account	205,275,000
Net cash provided by investing activities	(205,275,000)
Cash flows from financing activities:
Proceeds from issuance of Units, net of underwriting discounts paid	197,425,000
Proceeds from issuance of private placement warrants	10,000,000
Proceeds from issuance of Class B common stock to anchor investors	9,710
Proceeds from promissory note - related party	100,000
Payment of promissory note - related party	(162,892)
Payments for offering costs	(548,505)
Net cash provided by financing activities	206,823,313
Net change in cash	953,329
Cash at end of period	953,329
Supplemental disclosure of non-cash investing and financing activities
Offering costs paid by Sponsor in exchange for issuance of Class B Common Stock	23,404
Offering costs paid by promissory note	62,862
Deferred underwriting commissions in connection with the initial public offering	6,693,750
Offering costs included in accrued expenses	$ 259,794

DESCRIPTION OF ORGANIZATION A_3

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Artemis Strategic Investment Corporation (the “ Company Business Combination As of June 30, 2023, the Company had not yet commenced any operations. All activity since inception relates to the Company’s formation and the initial public offering (the “ Initial Public Offering IPO Prior to the consummation of the IPO, on January 5, 2021, Artemis Sponsor, LLC (the “ Sponsor Founder Shares Class B Common Stock On October 4, 2021, the Company consummated the Initial Public Offering of 20,125,000 units (the “ Units Public Shares Class A Common Stock one Public Warrants Certain institutional anchor investors (the “ Institutional Anchor Investors Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,000,000 warrants (the “ Sponsor Warrants Anchor Investor Warrants Private Placement Warrants Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial Business Combination on a one-for-one basis, subject to adjustment as provided in the Company’s final prospectus, as filed with the Securities and Exchange Commission (the “ SEC Final Prospectus Transaction costs amounted to $25,559,771 consisting of $3,825,000 of underwriting fees, $7,043,750 of deferred underwriting commissions, $13,796,426 of offering costs related to the fair value of the Founder Shares issued to certain Institutional Anchor Investors and $894,595 of other offering costs. Effective as of July 14, 2022, Barclays Capital Inc. (“ Barclays BMO Following the closing of the Initial Public Offering, an amount of $205,275,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “ Trust Account Investment Company Act The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to effect a Business Combination successfully. The Company will provide its holders of the outstanding Public Shares (the “ Public Stockholders If the Company conducts redemptions of the Public Shares in connection with a Business Combination pursuant to the proxy solicitation rules in conjunction with a stockholder meeting instead of pursuant to the tender offer rules, the Company’s third amended and restated certificate of incorporation (the “ Certificate of Incorporation Exchange Act The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions, which prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ ASC If the Company is unable to conduct redemptions pursuant to the proxy solicitation rules as described above, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor, officers, directors, Institutional Anchor Investors, and advisors have agreed (a) to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment, (c) not to redeem any shares (including the Founder Shares) into cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company is unable to conduct redemptions pursuant to the proxy solicitation rules) or a vote to amend the provisions of the Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor and our officers, directors and advisors will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (or 21 months from the closing of the Initial Public Offering, if the Company has executed a definitive agreement for a Business Combination within 18 months from the closing of the Initial Public Offering) (the “ Combination Period Proposed Business Combination with Novibet On June 29, 2023, the Company held a special meeting of its stockholders in lieu of an annual meeting of stockholders (the “2023 Special Meeting”). At the 2023 Special Meeting, the Company’s stockholders approved a proposal to amend the Company’s third amended and restated certificate of incorporation (the “Certificate of Incorporation”) to provide the Company with the right to extend the date by which the Company must consummate its initial business combination (the “Extension”), from July 4, 2023 to October 4, 2023 (the “Extended Date”) and to allow the Company, without another stockholder vote, by resolution of the Company’s board of directors, to elect to further extend the Extended Date in one-month increments up to six additional times, or a total of up to nine months total, up to April 4, 2024 (the “Extension Amendment Proposal”). In connection with the Extension, the Sponsor agreed to deposit into the Trust Account as a loan, (i) on July 5, 2023, an amount equal to the lesser of (x) $180,000 or (y) $0.105 per public share multiplied by the number of public shares outstanding, and (ii) one business day following the public announcement by the Company disclosing that the Company’s board of directors has determined to further extend the date by which the Company must consummate a business combination for an additional month, for each additional month up to April 4, 2024, an amount equal to the lesser of (x) $60,000 or (y) $0.035 per public share multiplied by the number of public shares outstanding. The Company’s stockholders also approved a proposal (the “Redemption Limitation Amendment Proposal”) to amend the Certificate of Incorporation to eliminate (i) the limitation that the Company may not redeem public shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 and (ii) the limitation that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such business combination. The Company’s stockholders also approved a proposal (the “Founder Share Amendment Proposal” and together with the Extension Amendment Proposal and Redemption Limitation Amendment Proposal, the “Charter Amendment Proposals”) to provide for the right of a holder of the Company’s Class B common stock, par value $0.0001 per share, to convert such shares into Class A common stock, par value $0.0001 per share, on a one-for-one basis at any time and from time to time prior to the closing of a business combination at the election of the holder. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act The Institutional Anchor Investors will not be entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period), see Note 5. Proposed Business Combination with Novibet On March 28, 2022, the board of directors of Artemis unanimously approved the Agreement and Plan of Reorganization, dated as of March 30, 2022, and amended on September 2, 2022 and December 14, 2022 (as the same may be further amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement Komisium Novibet PubCo Merger Sub Share Exchange Merger Proposed Business Combination Pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the Effective Time, Komisium will sell and transfer all issued ordinary shares and other equity interests of Novibet to PubCo in consideration for receiving at closing of the Proposed Business Combination (a) an amount of cash, which will not exceed $50 million, equal to the excess of the Gross Closing Proceeds (as defined in the Business Combination Agreement) over $100 million (the “ Closing Cash Consideration PubCo Ordinary Shares Closing Share Consideration (“ Initial Share Premium Additional Closing Share Consideration Deferred Share Consideration Earnout Consideration Additionally, pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the effective time of the Merger (the “ Effective Time Warrant Agreement On September 2, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 1 to the Business Combination Agreement, which among other things provided for (i) a closing share valuation of $500,000,000, with 12,254,902 PubCo Ordinary Shares issuable to Komisium at closing of the Proposed Business Combination if redemptions equal or exceed 85%, or if redemptions are less than 85%, then such PubCo Ordinary Shares would be deferred and issuable in subsequent years if certain earnout targets are met, (ii) a dual tranche earnout based on the achievement of certain net gaming revenue targets, (iii) clauses permitting Komisium to transfer up to 30% of the issued PubCo Ordinary Shares after the Closing, (iv) the payment of an amount of dividend declared prior to March 30, 2022 to Komisium up to the amount of €3,579,625, (v) the payment of the net profits generated by Novibet between signing and closing to Komisium, and (vi) a minimum cash closing condition of $12.5 million after transaction expenses and redemptions. On December 14, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 2 to the Business Combination Agreement, which among other things provided for (i) the change of Pubco’s jurisdiction of incorporation from England and Wales to Jersey and (ii) clauses permitting Komisium to transfer up to 10% of the issued Novibet ordinary shares prior to the Closing Date. In connection with the execution of the Business Combination Agreement, the Sponsor, Novibet and the Company entered into a Sponsor Support Agreement on March 30, 2022 (the “ Sponsor Support Agreement The closing of the Proposed Business Combination is subject to certain closing conditions and there is no assurance that the Proposed Business Combination will be completed. On June 2, 2023, the Company informed Novibet, Komisium, and the other parties to the Business Combination Agreement of its decision to terminate the Business Combination Agreement, with immediate effect. The termination was made pursuant to the Business Combination Agreement. In addition, pursuant to the Sponsor Support Agreement, the termination of the Business Combination Agreement also terminated the Sponsor Support Agreement. Liquidity and Going Concern Consideration As of June 30, 2023, the Company had $51,409 in cash and a working capital deficit of $6,999,802. The Company’s liquidity needs through June 30, 2023, were satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (defined below, see Note 5). As of June 30, 2023, there were no amounts outstanding under the Working Capital Loans. The Company’s management plans to continue its efforts to complete a Business Combination, which includes the Company’s most recent announcement related to a Definitive Merger Agreement with Danam Health, Inc., via Form 8-K filed with the SEC on Monday August 7 th If the Company’s funds are insufficient to meet the expenditures required for operating its business in the attempt to find a Business Combination or in the event that an initial Business Combination is not consummated, the Company will likely need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through October 4, 2023. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be unable to raise additional capital. In connection with the vote to approve the Charter Amendment Proposals, the holders of 18,012,973 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.49 per share (the “ Redemptions	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Artemis Strategic Investment Corporation (the “ Company Business Combination As of December 31, 2022, the Company had not yet commenced any operations. All activity since inception relates to the Company’s formation and the initial public offering (the “ Initial Public Offering IPO Prior to the consummation of the IPO, on January 5, 2021, Artemis Sponsor, LLC (the “ Sponsor per share (“ Founder Shares Class B Common Stock On October 4, 2021, the Company consummated the Initial Public Offering of 20,125,000 units (the “ Units Public Shares Class A Common Stock one Public Warrants shares of Class B Common Stock were no longer subject to forfeiture. Certain institutional anchor investors (the “ Institutional Anchor Investors Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,000,000 warrants (the “ Sponsor Warrants Anchor Investor Warrants Private Placement Warrants Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial Business Combination on a one-for-one basis, subject to adjustment as provided in the Company’s final prospectus, as filed with the Securities and Exchange Commission (the “ SEC Final Prospectus Transaction costs amounted to $25,559,771 consisting of $3,825,000 of underwriting fees, $7,043,750 of deferred underwriting commissions, $13,796,426 of offering costs related to the fair value of the Founder Shares issued to certain Institutional Anchor Investors and $894,595 of other offering costs. Effective as of July 14, 2022, Barclays Capital Inc. (“ Barclays withdrew from its role as financial advisor and capital markets advisor to the Company and waived its entitlement to all fees in connection with the Business Combination, including its portion of the deferred underwriting commissions in the amount of approximately $4,578,438. Effective as of July 20, 2022, BMO Capital Markets Corp. (“ BMO $13,158,020 $638,407 Following the closing of the Initial Public Offering, an amount of $205,275,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “ Trust Account Investment Company Act The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to effect a Business Combination successfully. The Company will provide its holders of the outstanding Public Shares (the “ Public Stockholders If the Company conducts redemptions of the Public Shares in connection with a Business Combination pursuant to the proxy solicitation rules in conjunction with a stockholder meeting instead of pursuant to the tender offer rules, the Company’s third amended and restated certificate of incorporation (the “ Certificate of Incorporation Exchange Act The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.20 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions, which prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ ASC If the Company is unable to conduct redemptions pursuant to the proxy solicitation rules as described above, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor, officers, directors, Institutional Anchor Investors, and advisors have agreed (a) to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment, (c) not to redeem any shares (including the Founder Shares) into cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company is unable to conduct redemptions pursuant to the proxy solicitation rules) or a vote to amend the provisions of the Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor and our officers, directors and advisors will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (or 21 months from the closing of the Initial Public Offering, if the Company has executed a definitive agreement for a Business Combination within 18 months from the closing of the Initial Public Offering) (the “ Combination Period Proposed Business Combination with Novibet The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act The Institutional Anchor Investors will not be entitled to (i) redemption rights with respect to any Founder Shares held by them in connection with the completion of the initial Business Combination, (ii) redemption rights with respect to any Founder Shares held by them in connection with a stockholder vote to amend the Certificate of Incorporation in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (iii) rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period), see Note 5. Proposed Business Combination with Novibet On March 28, 2022, the board of directors of Artemis unanimously approved the Agreement and Plan of Reorganization, dated as of March 30, 2022, and amended on September 2, 2022 (as the same may be further amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement Komisium Novibet PubCo Merger Sub Share Exchange Merger Proposed Business Combination Pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the Effective Time, Komisium will sell and transfer all issued ordinary shares and other equity interests of Novibet to PubCo in consideration for receiving at closing of the Proposed Business Combination (a) an amount of cash, which will not exceed $50 million, equal to the excess of the Gross Closing Proceeds (as defined in the Business Combination Agreement) over $100 million (the “ Closing Cash Consideration PubCo Ordinary Shares Closing Share Consideration Initial Share Premium Additional Closing Share Consideration Deferred Share Consideration Earnout Consideration Additionally, pursuant to the Business Combination Agreement, subject to the satisfaction or waiver of certain closing conditions set forth therein, immediately prior to the effective time of the Merger (the “ Effective Time share of Class A Common Stock subject to the terms of the Company’s Certificate of Incorporation and the Sponsor Support Agreement, (b) each issued and outstanding share of Class A Common Stock (including the shares of Class A Common Stock issued upon conversion of shares of Class B Common Stock, but not including any shares redeemed by the Public Stockholders and certain other excluded Company shares) shall no longer be outstanding and will be automatically converted into the right of the holder thereof to receive Warrant Agreement On September 2, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 1 to the Business Combination Agreement, which among other things provided for (i) a closing share valuation of $500,000,000, with 12,254,902 PubCo Ordinary Shares issuable to Komisium at closing of the Proposed Business Combination if redemptions equal or exceed 85%, or if redemptions are less than 85%, then such PubCo Ordinary Shares would be deferred and issuable in subsequent years if certain earnout targets are met, (ii) a dual tranche earnout based on the achievement of certain net gaming revenue targets, (iii) clauses permitting Komisium to transfer up to 30% of the issued PubCo Ordinary Shares after the Closing, (iv) the payment of an amount of dividend declared prior to March 30, 2022 to Komisium up to the amount of €3,579,625, (v) the payment of the net profits generated by Novibet between signing and closing to Komisium, and (vi) a minimum cash closing condition of $12.5 million after transaction expenses and redemptions. On December 14, 2022, Komisium, Novibet, PubCo, Merger Sub and the Company entered into Amendment No. 2 to the Business Combination Agreement, which among other things provided for (i) the change of Pubco’s jurisdiction of incorporation from England and Wales to Jersey and (ii) clauses permitting Komisium to transfer up to 10% of the issued Novibet ordinary shares prior to the Closing Date. In connection with the execution of the Business Combination Agreement, the Sponsor, Novibet and the Company entered into a Sponsor Support Agreement on March 30, 2022 (the “ Sponsor Support Agreement The closing of the Proposed Business Combination is subject to certain closing conditions and there is no assurance that the Proposed Business Combination will be completed. Liquidity and Going Concern Consideration As of December 31, 2022, the Company had $160,940 in cash and a working capital deficit of $5,942,600. The Company’s liquidity needs through December 31, 2022, were satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (defined below, see Note 5). As of December 31, 2022, there were no amounts outstanding under the Working Capital Loans. The Company’s management plans to continue its efforts to complete a Business Combination within 21 months of the closing of the Initial Public Offering, or July 4, 2023. If the Company’s funds are insufficient to meet the expenditures required for operating its business in the attempt to find a Business Combination or in the event that an initial Business Combination is not consummated, the Company will likely need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through July 4, 2023. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be unable to raise additional capital.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2022
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company had recognized a liability upon closing of its initial public offering in October 2021 for a portion of the underwriter’s commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial discount to the securities sold in the initial public offering. The underwriter waived all claims to this deferred commission in July 2022. The Company recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of operations for the three and nine months ended September 30, 2022. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent liability as a credit to stockholders’ deficit. Therefore, on March 30, 2023, the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded that the Company’s previously issued unaudited interim financial statements as of and for the three and nine months ended September 30, 2022 (the “Third Quarter 10-Q”) should no longer be relied upon and that it is appropriate to restate the Third Quarter 10-Q. As such, this Annual Report contains the restated statement of operations, statement of changes in stockholder’s deficit, and statement of cash flows for the three and nine months ended September 30, 2022. Other than as described above, this Annual Report does not reflect adjustments for events occurring after the filing of the Third Quarter 10-Q except to the extent that they are otherwise required to be included and discussed herein. Impact of the Restatement The impact of the restatement on the statements of operations, statements of changes in stockholders’ deficit and statements of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statement of Operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended September 30, 2022 (unaudited) ​ ​ As Previously ​ Restatement ​ ​ ​ Reported Adjustment As Restated Loss from operations ​ $ 722,149 ​ $ — ​ $ 722,149 Other income (expenses): ​ ​ ​ Gain from derecognition of deferred underwriting fee payable ​ 7,043,750 ​ (6,717,612) ​ 326,138 Total other income (expenses) ​ 7,831,954 ​ (6,717,612) ​ 1,114,342 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 7,109,805 ​ $ (6,717,612) ​ $ 392,193 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding – Class A common stock ​ 20,125,000 ​ — ​ 20,125,000 Basic and diluted earnings per share – Class A common stock ​ $ 0.28 ​ $ (0.26) ​ $ 0.02 Basic and diluted weighted average shares outstanding – Class B common stock ​ 5,031,250 ​ — ​ 5,031,250 Basic and diluted earnings per share – Class B common stock ​ $ 0.28 ​ $ (0.26) ​ $ 0.02 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, 2022 (unaudited) ​ ​ As Previously ​ Restatement ​ ​ ​ Reported Adjustment As Restated Loss from operations ​ $ 5,776,498 ​ $ — ​ $ 5,776,498 Other income (expenses): ​ ​ ​ Gain from derecognition of deferred underwriting fee payable ​ 7,043,750 ​ (6,717,612) ​ 326,138 Total other income (expenses) ​ 16,149,616 ​ (6,717,612) ​ 9,432,004 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 10,373,118 ​ $ (6,717,612) ​ $ 3,655,506 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding – Class A common stock ​ 20,125,000 ​ — ​ 20,125,000 Basic and diluted earnings per share – Class A common stock ​ $ 0.41 ​ $ (0.26) ​ $ 0.15 Basic and diluted weighted average shares outstanding – Class B common stock ​ 5,031,250 ​ — ​ 5,031,250 Basic and diluted earnings per share – Class B common stock ​ $ 0.41 ​ $ (0.26) ​ $ 0.15 ​ Statement of Changes in Stockholders’ Deficit: (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Additional Accumulated Deficit Total ​ ​ Stock ​ Paid-In ​ As Previously ​ Restatement ​ ​ ​ ​ Stockholders ​ Shares Amount Capital Reported Adjustment As Restated Deficit Balance – June 30, 2022 5,031,250 ​ $ 503 ​ $ — ​ $ (12,620,313) ​ — ​ $ (12,620,313) ​ $ (12,610,810) Adjustment for accretion of Class A common stock subject to possible redemption amount — ​ — ​ — ​ (1,265,293) ​ 6,717,612 ​ 5,452,319 ​ 5,452,319 Net income — ​ — ​ — ​ 7,109,805 ​ (6,717,612) ​ 392,193 ​ 392,193 Balance – September 30, 2022 5,031,250 ​ $ 503 ​ $ — ​ $ (6,775,801) ​ $ — ​ $ (6,775,801) ​ $ (6,775,298) ​ Statement of Cash Flows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, 2022 (unaudited) ​ ​ As Previously ​ Restatement ​ ​ ​ Reported Adjustment As Restated Cash Flows from Operating Activities: ​ ​ ​ ​ ​ ​ Net income ​ $ 10,373,118 ​ $ (6,717,612) ​ $ 3,655,506 Adjustments to reconcile net income to net cash used in operating activities: ​ ​ ​ ​ Gain from derecognition of deferred underwriting fee payable ​ (7,043,750) ​ 6,717,612 ​ (326,138) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net change in cash ​ $ (621,952) ​ $ — ​ $ (621,952) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Supplemental disclosure of noncash activities: ​ ​ ​ Gain from derecognition of deferred underwriting fee payable allocated to Class A common stock ​ $ — ​ $ 6,717,612 ​ $ 6,717,612 ​

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2023. The interim results for the three months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of June 30, 2023 and December 31, 2022, 2,112,027 and 20,125,000 shares of Class A common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company had $1,589,736 and $1,316,585 of deferred income tax assets at June 30, 2023 and December 31, 2022, respectively, and a full valuation allowance at the end of each period. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. As of June 30, 2023 and December 31, 2022, income taxes payable of $647,396 and $591,919, respectively, are included in accounts payable and accrued expenses on the Company’s condensed balance sheet. Net Income/(Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income/(Loss) per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income/(Loss) is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. On June 29, 2023, the Company issued an aggregate of 3,412,816 shares of non-redeemable Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (“Founder Share Conversion”). The 3,412,816 shares of non-redeemable Class A common stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B common stock before the Founder Share Conversion (see Note 5). The Company’s basic and diluted income/(loss) per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended Six Months Ended Six Months Ended ​ ​ June 30, 2023 ​ June 30, 2022 ​ June 30, 2023 ​ June 30, 2022 Class A Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class A Common Stock ​ $ 1,115,145 ​ $ 3,614,039 ​ $ 3,141,106 ​ $ 2,610,650 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 19,588,855 ​ ​ 20,125,000 ​ 19,745,490 ​ ​ 20,125,000 Net income/(loss) per share, Class A, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class B common stock ​ $ 278,786 ​ $ 903,510 ​ ​ 785,277 ​ ​ 652,662 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 4,902,371 ​ ​ 5,031,250 ​ 4,938,965 ​ ​ 5,031,250 Net income/(loss) per share, Class B, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 (including deferred underwriting commissions of an aggregate of approximately $ 7,043,750 which, prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters of the IPO upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively) Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ASC 815-40”). Such warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statement of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of any warrants. At that time, the portion of the warrant liabilities related to the warrants will be reclassified to additional paid-in capital. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and December 31, 2021. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of December 31, 2022 and December 31, 2021, 20,125,000 shares of Class A Common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. At December 31, 2022 the Company had $1,316,585 of deferred income tax assets and at December 31, 2021, the Company’s deferred income tax assets are deemed to be de minimis. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. Net Income per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. The Company’s basic and diluted net income per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the ​ ​ For the period from ​ ​ Year Ended ​ ​ January 4, 2021 to ​ ​ ​ December 31, 2022 ​ ​ December 31, 2021 Class A Common Stock ​ ​ ​ ​ ​ ​ Numerator: Net income allocable to Class A Common Stock ​ $ 2,783,672 ​ $ 162,830 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 20,125,000 ​ 4,947,859 Net income per share, Class A, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ Numerator: Net income allocable to Class B common stock ​ $ 695,918 ​ $ 149,288 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 5,031,250 ​ 4,536,343 Net income per share, Class B, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 was charged to temporary equity, and Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ ASC 815-40 Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

INITIAL PUBLIC OFFERING_2

INITIAL PUBLIC OFFERING	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 20,125,000 Units , including the 2,625,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, one Public Warrant	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 20,125,000 Units , including the 2,625,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, one Public Warrant

PRIVATE PLACEMENT_2

PRIVATE PLACEMENT	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased 8,000,000 Private Placement Warrants at a price of $1.00 per warrant, generating total proceeds of $8,000,000 to the Company. Substantially concurrently with the closing of the Private Placement, the Sponsor sold an aggregate of 2,000,000 Private Placement Warrants to certain Institutional Anchor Investors for at a price of $1.00 per warrant, generating total proceeds of $2,000,000 to the Company. Each Private Placement Warrant is identical to the Public Warrants in material terms and provisions, except that the Private Placement Warrants will be non-redeemable (except as described below in Note 7 under “ Redemption of Warrants for Class A Common Stock	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased 8,000,000 Private Placement Warrants at a price of $1.00 per warrant, generating total proceeds of $8,000,000 to the Company. Substantially concurrently with the closing of the Private Placement, the Sponsor sold an aggregate of 2,000,000 Private Placement Warrants to certain Institutional Anchor Investors for at a price of $1.00 per warrant, generating total proceeds of Each Private Placement Warrant is identical to the Public Warrants in material terms and provisions, except that the Private Placement Warrants will be non-redeemable (except as described below in Note 7 under “ Redemption of Warrants for Class A Common Stock

RELATED PARTY TRANSACTIONS_2

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On January 5, 2021, the Company issued 4,312,500 Founder Shares to the Sponsor in consideration for the Sponsor paying certain offering and formation costs on behalf of the Company with a value of $25,000. On March 16, 2021, the Company effected a stock split of the Founder Shares, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor. All share and per share amounts have been retroactively restated to reflect the stock split. Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Public Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days In connection with the closing of the Initial Public Offering the Sponsor sold an aggregate of 1,618,434 Founder Shares to the Institutional Anchor Investors at their original purchase price. The Company estimated the aggregate fair value of these Founder Shares attributable to the Institutional Anchor Investors to be $13,796,426, or $8.54 per share. The fair value of the Founder Shares were valued using a binomial/lattice model. The excess of the fair value of the Founder Shares over cost was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost was allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. On June 29, 2023, the Company issued an aggregate of 3,412,816 shares of non-redeemable Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (“ Founder Share Conversion Promissory Note — Related Party On January 5, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “ Note Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“ Working Capital Loans Administrative Support Agreement The Company entered into an agreement, commencing on September 30, 2021, to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative support. Upon completion of the Proposed Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 in accordance with the terms of the agreement during the three months ended June 30, 2023, incurred $60,000 and paid $20,000 in accordance with the terms of the agreement, during the six months ended June 30, 2023 and incurred and paid $30,000 and $60,000 in accordance with the terms of the agreement during the three and six months ended June 30, 2022, respectively.	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On January 5, 2021, the Company issued 4,312,500 Founder Shares to the Sponsor in consideration for the Sponsor paying certain offering and formation costs on behalf of the Company with a value of $25,000. On March 16, 2021, the Company effected a stock split of the Founder Shares, resulting in an aggregate of 5,031,250 Founder Shares outstanding and held by the Sponsor. All share and per share amounts have been retroactively restated to reflect the stock split. Simultaneously with the closing the Initial Public Offering, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Public Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their Public Shares for cash, securities or other property. In connection with the closing of the Initial Public Offering the Sponsor sold an aggregate of 1,618,434 Founder Shares to the Institutional Anchor Investors at their original purchase price. The Company estimated the aggregate fair value of these Founder Shares attributable to the Institutional Anchor Investors to be $13,796,426, or $8.54 per share. The fair value of the Founder Shares were valued using a binomial/lattice model. The excess of the fair value of the Founder Shares over cost was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost was allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Promissory Note — Related Party On January 5, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “ Note Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“ Working Capital Loans Administrative Support Agreement The Company entered into an agreement, commencing on September 30, 2021, to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative support. Upon completion of the Proposed Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred and paid $120,000 and $30,000 in accordance with the terms of the agreement, during the year ended December 31, 2022 and for the period from January 4, 2021 (Inception) to December 31 2021, respectively.

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of macroeconomic conditions, such as the COVID-19 pandemic, downturns in the financial markets, inflation, declines in consumer spending, increases in interest rates, and geopolitical instability such as the war in Ukraine, on the industry and has concluded that while it is reasonably possible that such macroeconomic conditions could have a negative effect on the Company’s financial position, results of its operations, search for a target company and/or the completion of a Business Combination, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, the Inflation Reduction Act of 2022 (the “ IR Act covered corporation The extent of the excise tax that may be incurred would depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the excise tax, (ii) the fair market value of the redemption treated as a repurchase of stock in connection with the Proposed Business Combination, (iii) the nature and amount of the equity issued, if any, by us in connection with the Proposed Business Combination, and (iv) the content of forthcoming regulations and other guidance from the U.S. Department of the Treasury. Although issuances of stock by a repurchasing corporation in a year in which such corporation repurchases stock may reduce the amount of excise tax imposed with respect to such repurchase, absent the issuance of applicable guidance, it is not currently expected that this reduction would be available with respect to redemptions of Class A Common Stock by the Company and the issuance of shares in connection with the Proposed Business Combination. The excise tax is imposed on the repurchasing corporation itself, not the stockholders from which shares are repurchased, and only limited guidance on the mechanics of any required reporting and payment of the excise tax on which taxpayers may rely have been issued to date. The imposition of the excise tax could reduce the amount of cash available the Company us for effecting the redemptions of Class A Common Stock, and could reduce the cash on hand for the Company (and PubCo immediately following the Proposed Business Combination) to fund operations and to make distributions to stockholders. Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement signed in connection with the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Public Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters, prior to their respective resignation and waiver of fees, were entitled to deferred underwriting commissions of $0.35 per Unit, or $7,043,750 in the aggregate. The deferred underwriting commissions were expected to become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, dated September 29, 2021, among Barclays, BMO and the Company. On July 14, 2022, Barclays delivered to the Company a notice of resignation of its roles as financial and capital markets advisor to the Company in connection with the Business Combination and waived all rights to fees (including deferred underwriting commissions for services rendered as one of the underwriters in the Company’s IPO) and reimbursement of expenses in connection with the Business Combination. On July 20, 2022, BMO, one of the underwriters in the IPO, delivered to the Company a notice that BMO waived all rights to its portion of the deferred underwriting commissions in connection with the IPO. BMO had no role in connection with the Business Combination. As a result of the Barclays’ resignation letter and BMO’s waiver notice, the Company recorded a gain on derecognition of deferred underwriting fees payable of $326,138 within the Statement of Operations and $6,717,612 was recorded as an adjustment for accretion of Class A common stock subject to possible redemption amount for the year ended December 31, 2022.	NOTE 7. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of macroeconomic conditions, such as the COVID-19 pandemic, downturns in the financial markets, inflation, declines in consumer spending, increases in interest rates, and geopolitical instability such as the war in Ukraine, on the industry and has concluded that while it is reasonably possible that such macroeconomic conditions could have a negative effect on the Company’s financial position, results of its operations, search for a target company and/or the completion of a Business Combination, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, the Inflation Reduction Act of 2022 (the “ IR Act Treasury Any repurchase by the Company of the Company’s stock that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, is generally expected to be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax on a redemption of Class A Common Stock or other stock of the Company in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the excise tax, (ii) the fair market value of the redemption treated as a repurchase of stock in connection with the Business Combination, extension or otherwise, (iii) the structure of a Business Combination, (iv) the nature and amount of any proposed “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a redemption treated as a repurchase of stock) and (v) the content of regulations and other guidance from the Treasury. As noted above, the excise tax would be payable by the Company and not by the redeeming holder. The imposition of the excise tax could cause a reduction in the cash available on hand to complete a Business Combination or for effecting redemptions and may affect the Company’s ability to complete a Business Combination, including the proposed Business Combination with Novibet. Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement signed in connection with the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Public Shares). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters, prior to their respective resignation and waiver of fees, were entitled to deferred underwriting commissions of $0.35 per Unit, or $7,043,750 in the aggregate. The deferred underwriting commissions were expected to become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, dated September 29, 2021, among Barclays, BMO and the Company. On July 14, 2022, Barclays delivered to the Company a notice of resignation of its roles as financial and capital markets advisor to the Company in connection with the Business Combination and waived all rights to fees (including deferred underwriting commissions for services rendered as one of the underwriters in the Company’s IPO) and reimbursement of expenses in connection with the Business Combination. On July 20, 2022, BMO, one of the underwriters in the IPO, delivered to the Company a notice that BMO waived all rights to its portion of the deferred underwriting commissions in connection with the IPO. BMO had no role in connection with the Business Combination. As a result of the Barclays’ resignation letter and BMO’s waiver notice, the Company recorded a gain on derecognition of deferred underwriting fees payable of $326,138 within the accompanying statements of operations.

WARRANT LIABILITIES_2

WARRANT LIABILITIES	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
WARRANT LIABILITIES
WARRANT LIABILITIES	NOTE 7. WARRANT LIABILITIES The Company accounted for 20,062,500 warrants issued in connection with the Initial Public Offering ( 10,062,500 Public Warrants and 10,000,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant is recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The warrants will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares of Class A Common Stock to holders seeking to exercise their warrants, unless the issuance of the shares of Class A Common Stock issuable upon such warrant exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A Common Stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire, as specified in the Warrant Agreement. If any such registration statement has not been declared effective by the 60 th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A Common Stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the Class A Common Stock under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Redemption of Public Warrants for Cash The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported closing price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Redemption of Warrants for Class A Common Stock The Company may redeem the Public Warrants: ● in whole and not in part; ● at $ 0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined as set out in the Warrant Agreement, based on the redemption date and the “fair market value” of the Class A Common Stock except as otherwise described below; ● if, and only if, the last reported sale price of the Class A Common Stock equals or exceeds $ 10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A Common Stock) as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30 -day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the Warrant Agreement. Additionally, in no event will the Company be required to net cash settle any warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “ Newly Issued Price ”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “ Market Value ”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $ 10.00 per share redemption trigger price described above shall be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.	NOTE 8. WARRANT LIABILITIES The Company accounted for 20,062,500 warrants issued in connection with the Initial Public Offering (10,062,500 Public Warrants and 10,000,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant is recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The warrants will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of shares of Class A Common Stock issuable upon exercise of the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares of Class A Common Stock to holders seeking to exercise their warrants, unless the issuance of the shares of Class A Common Stock issuable upon such warrant exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A Common Stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A Common Stock until the warrants expire, as specified in the Warrant Agreement. If any such registration statement has not been declared effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A Common Stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the Class A Common Stock under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Redemption of Public Warrants for Cash The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported closing price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Redemption of Warrants for Class A Common Stock The Company may redeem the Public Warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined as set out in the Warrant Agreement, based on the redemption date and the “fair market value” of the Class A Common Stock except as otherwise described below; ● if, and only if, the last reported sale price of the Class A Common Stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A Common Stock) as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30 -day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the Warrant Agreement. Additionally, in no event will the Company be required to net cash settle any warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the holders or such affiliates, as applicable, prior to such issuance) (the “ Newly Issued Price Market Value

CLASS A COMMON STOCK SUBJECT _4

CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION	NOTE 8. CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 380,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 20,125,000 shares of Class A Common Stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets. The Class A Common Stock subject to possible redemption reflected on the balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ ​ (11,247,232) Plus: ​ ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 205,275,000 Accretion of Class A common stock subject to possible redemption amount ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 207,501,604 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,558,841 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 209,060,445 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,291,243 Redemption of Class A common stock on June 29, 2023 ​ ​ (189,038,189) Class A common stock subject to possible redemption at June 30, 2023 ​ $ 21,313,499 ​	NOTE 9. CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 380,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of December 31, 2022 and December 31, 2021, there were 20,125,000 shares of Class A Common Stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheets. The Class A Common Stock subject to possible redemption reflected on the balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ (11,247,232) Plus: ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ $ 205,275,000 Accretion of Class A common stock subject to possible redemption amount, ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ $ 207,501,604 ​

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
STOCKHOLDER'S DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 9. STOCKHOLDER’S DEFICIT Preferred Stock — Class A Common Stock outstanding Class B Common Stock — there were 5,031,250 shares of Class B Common Stock issued and outstanding Simultaneously with the closing of the Initial Public Offering on October 4, 2021, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial business combination on a one-for-one basis , subject to adjustment as provided in the Final Prospectus. Holders of the Class A Common Stock and holders of the Founder Shares will vote together as a single class on all matters submitted to a vote of our stockholders, except as required by law or stock exchange rule; provided that only holders of the Founder Shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination and holders of a majority of the Founder Shares may remove a member of the board of directors for any reason. The Founder Shares will automatically convert into Class A Common Stock at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of shares of Class A Common Stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of (i) the total number of all shares of Class A Common Stock issued in the Offering (including any shares of Class A Common Stock issued pursuant to the underwriters’ over-allotment option) plus (ii) the sum of (i) all shares of Class A Common Stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued in connection with or in relation to the consummation of a Business Combination (including any shares of Class A Common Stock issued pursuant to a forward purchase agreement), excluding any shares of Class A Common Stock or equity-linked securities or rights issued, or to be issued, to any seller in a Business Combination, any Private Placement Warrants issued to the Sponsor, or an affiliate of the Sponsor, or any member of management team upon conversion of Working Capital Loans and any warrants issued pursuant to a forward purchase agreement, minus (ii) the number of shares of Class A Common Stock redeemed in connection with a Business Combination, provided that such conversion of Founder Shares shall never be less than one-to-one. The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.	NOTE 10. STOCKHOLDERS’ DEFICIT Preferred Stock — Class A Common Stock Class B Common Stock — Simultaneously with the closing of the Initial Public Offering on October 4, 2021, the Sponsor forfeited 1,618,434 Founder Shares and the Company sold 1,618,434 Founder Shares to certain Institutional Anchor Investors at the original purchase price of $0.006 per share. The Founder Shares will automatically convert into shares of Class A Common Stock at the time of the Company’s initial business combination on a one -for-one basis, subject to adjustment as provided in the Final Prospectus. Holders of the Class A Common Stock and holders of the Founder Shares will vote together as a single class on all matters submitted to a vote of our stockholders, except as required by law or stock exchange rule; provided that only holders of the Founder Shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination and holders of a majority of the Founder Shares may remove a member of the board of directors for any reason. The Founder Shares will automatically convert into Class A Common Stock at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of shares of Class A Common Stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of (i) the total number of all shares of Class A Common Stock issued in the Offering (including any shares of Class A Common Stock issued pursuant to the underwriters’ over-allotment option) plus (ii) the sum of (i) all shares of Class A Common Stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued in connection with or in relation to the consummation of a Business Combination (including any shares of Class A Common Stock issued pursuant to a forward purchase agreement), excluding any shares of Class A Common Stock or equity-linked securities or rights issued, or to be issued, to any seller in a Business Combination, any Private Placement Warrants issued to the Sponsor, or an affiliate of the Sponsor, or any member of management team upon conversion of Working Capital Loans and any warrants issued pursuant to a forward purchase agreement, minus (ii) the number of shares of Class A Common Stock redeemed in connection with a Business Combination, provided that such conversion of Founder Shares shall never be less than one-to-one. The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2022
INCOME TAXES
INCOME TAXES	NOTE 11. INCOME TAXES The Company had $1,316,585 of deferred tax assets as of December 31, 2022 and did not have any significant deferred tax assets or liabilities as of December 31, 2021. The Company’s net deferred tax assets are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ December 31, 2021 Deferred tax asset ​ ​ Organizational costs/Startup expenses ​ $ 1,316,585 ​ $ 272,783 Total deferred tax asset ​ 1,316,585 ​ 272,783 Valuation allowance ​ (1,316,585) ​ (272,783) Deferred tax asset, net of allowance ​ $ — ​ $ — ​ The income tax provision consists of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2022 ​ 2021 Federal: ​ ​ ​ ​ Current ​ $ 591,919 ​ $ — Deferred ​ (1,403,802) ​ (272,783) ​ ​ ​ ​ ​ ​ ​ State: ​ ​ ​ Current ​ $ — ​ $ — Deferred ​ — ​ — Change in valuation allowance ​ 1,043,802 ​ 272,783 Income tax provision ​ $ 591,919 ​ $ — ​ As of December 31, 2022 or December 31, 2021, the Company did not have any material U.S. federal and state net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2022 and for the period from January 4, 2021 (inception) through December 31, 2021, the change in the valuation allowance was $1,043,802 and $272,783, respectively. A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and December 31, 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, December 31, ​ ​ 2022 ​ 2021 Statutory federal income tax rate 21.0 % 21.0 % Tax effects of change in fair value of warrant liability (37.2) % (117.0) % Gain on deferred underwriting ​ (1.7) % ​ — ​ Net operating loss ​ 0.3 % ​ — ​ Tax effects of transaction costs allocated to warrant liability ​ — ​ ​ 78.0 % Change in valuation allowance 32.1 % 18.0 % Income tax provision 14.5 % — % ​ The Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination by the various taxing authorities.

FAIR VALUE MEASUREMENT_2

FAIR VALUE MEASUREMENT	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
FAIR VALUE MEASUREMENT
FAIR VALUE MEASUREMENT	NOTE 10. FAIR VALUE MEASUREMENT The following table presents information about the Company’s assets and liabilities that are measured at fair value at June 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, Description ​ Level ​ 2023 Assets: ​ ​ ​ ​ ​ Investments held in Trust Account, current 1 ​ $ 189,038,189 Investments held in Trust Account, noncurrent ​ 1 ​ $ 22,060,895 Liabilities: ​ ​ ​ ​ ​ Warrant liability – Public Warrants 2 ​ $ 292,819 Warrant liability – Private Placement Warrants 2 ​ $ 291,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000 ​ Warrants The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Balance Sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. The warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. As of June 30, 2023 and December 31, 2022, the fair value of the Private Placement Warrants was the equivalent to that of the Public Warrants as they had substantially the same terms; however, they are not actively traded, as such are listed as a Level 2 in the hierarchy table above.	NOTE 12. FAIR VALUE MEASUREMENT The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description Level 2021 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 205,284,883 Liabilities: ​ ​ Warrant liability – Public Warrants 1 ​ $ 4,943,706 Warrant liability – Private Placement Warrants 2 ​ $ 4,913,000 ​ Warrants The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Balance Sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. The warrants were initially valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. As of December 31, 2022 and December 31, 2021, the fair value of the Private Placement Warrants was the equivalent to that of the Public Warrants as they had substantially the same terms; however, they are not actively traded, as such are listed as a Level 2 in the hierarchy table above. Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. On November 22, 2021, the Public Warrants surpassed the 52-day threshold waiting period to be publicly traded in accordance with the Prospectus filed September 29, 2021. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of December 31, 2021, the Company classified the Public Warrants as Level 1. The estimated value of the Public Warrants and Private Placement Warrants transferred from a Level 3 measurement to a Level 1 measurement and Level 2 measurement, respectively from the initial measurement through December 31, 2021 was $9,856,706 as presented in the changes in fair value of Level 3 warrant liabilities table below. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private ​ ​ Warrant ​ ​ Placement ​ Public ​ Liabilities Fair value as of January 4, 2021 (inception) ​ $ — ​ $ — ​ $ — Initial measurement on October 4, 2021 ​ 5,780,000 ​ 5,816,125 ​ 11,596,125 Change in fair value ​ (867,000) ​ (872,419) ​ (1,739,419) Transfer to Level 1 ​ — ​ (4,943,706) ​ (4,943,706) Transfer to Level 2 ​ (4,913,000) ​ — ​ (4,913,000) Fair value as of December 31, 2021 ​ $ — ​ $ — ​ $ — ​

SUBSEQUENT EVENTS_2

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated events that have occurred up to the date the unaudited condensed financial statements were issued. Based upon the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed in Note 9 and the following: On July 5, 2023, the Company and Sponsor entered into a subscription agreement (“ Subscription Agreement Investor ● The Investor will make a cash contribution (the “ Capital Contribution ”) to Sponsor in an aggregate amount of $1 million, as follows: (i) an initial tranche of $400,000 , to be paid within two business days of the date of the Subscription Agreement, but no later than July 5, 2023, (ii) a second tranche of $300,000 , to be paid within two business days of the Company and Sponsor entering into a definitive agreement for the Company’s initial business combination, and (iii) a third tranche, subject to written approval of the Company, of $300,000 , to be paid within two business days of the Company submitting both an initial registration statement on Form S-4 with the SEC and amendments to such registration statement in response to comment letters from the SEC. ● The Capital Contribution will in turn be loaned by the Sponsor to the Company to cover working capital expenses (the “ SPAC Loan ”). The SPAC Loan will not accrue interest and will be repaid by the Company upon the closing of the Company’s initial business combination (the “ De-SPAC Closing ”). The Sponsor will pay to the Investor all repayments of the SPAC Loan the Sponsor has received within five business days of the De-SPAC Closing. The Investor may elect at the De-SPAC Closing to receive such payments in cash or shares of Class A common stock of the Company (“ Class A common stock ”) at a rate of one share of Class A common stock for each $10 of the Capital Contribution. ● In consideration for the Capital Contribution, at the De-SPAC Closing the Company will issue to the Investor one share of Class A common stock for each dollar of the Capital Contribution funded by the Investor. The Company agreed that such shares will not be subject to transfer restrictions or any other lock-up provisions, earn outs, or other contingencies and will be registered as part of any registration statement to be filed in connection with the business combination or, if no such registration statement is filed, will be registered as part of the first registration statement to be filed by the Company or the surviving entity following the De-SPAC Closing, which will be filed no later than 30 days after the De-SPAC Closing and be declared effective no later than 90 days after the De-SPAC Closing. ● If the SPAC or Sponsor defaults in its obligations under the Subscription Agreement and such default continues for a period of five business days following written notice, Sponsor agreed to immediately transfer to Investor 100,000 shares of Class A common stock and an additional 100,000 shares of Class A common stock each month thereafter until the default is cured, up to a maximum of 1 million shares of Class A common stock, subject to a 19.9% beneficial ownership limitation set forth in the Subscription Agreement. ● On the De-SPAC Closing, the Sponsor will pay the Investor an amount equal to the reasonable attorney fees incurred by the Investor in connection with the Subscription Agreement not to exceed $5,000 . On July 5, 2023, the Sponsor advanced $400,000 to the Company, of which $180,000 was contributed to the Trust Account for the initial three-month period of the extension. On July 31, 2023, Thomas Granite resigned from his role as Chief Financial Officer position with the Company. On August 3, 2023, the board of directors of the Company appointed Philip Kaplan, the Company’s current Co-Chief Executive Officer and President, as the Principal Financial and Accounting Officer of the Company, succeeding Thomas Granite. On August 7, 2023, the Company and Danam Health, Inc. announced the execution of a Definitive Merger Agreement. Danam Health, Inc. is a health services technology and pharmaceutical distribution company pioneering an ecosystem model designed to empower various stakeholders in the prescription journey and patient medication compliance aspects of healthcare.	NOTE 13. SUBSEQUENT EVENTS The Company evaluated events that have occurred up to the date the financial statements were issued. Based upon the review, management did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2023. The interim results for the three months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.	Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and December 31, 2021.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of the U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of June 30, 2023 and December 31, 2022, 2,112,027 and 20,125,000 shares of Class A common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.	Class A Common Stock Subject to Possible Redemption All of the 20,125,000 shares of Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Proposed Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A Common Stock (including Class A Common Stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. As of December 31, 2022 and December 31, 2021, 20,125,000 shares of Class A Common Stock subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A Common Stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company had $1,589,736 and $1,316,585 of deferred income tax assets at June 30, 2023 and December 31, 2022, respectively, and a full valuation allowance at the end of each period. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. As of June 30, 2023 and December 31, 2022, income taxes payable of $647,396 and $591,919, respectively, are included in accounts payable and accrued expenses on the Company’s condensed balance sheet.	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. At December 31, 2022 the Company had $1,316,585 of deferred income tax assets and at December 31, 2021, the Company’s deferred income tax assets are deemed to be de minimis. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
Net Income per Common Share	Net Income/(Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income/(Loss) per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income/(Loss) is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. On June 29, 2023, the Company issued an aggregate of 3,412,816 shares of non-redeemable Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (“Founder Share Conversion”). The 3,412,816 shares of non-redeemable Class A common stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B common stock before the Founder Share Conversion (see Note 5). The Company’s basic and diluted income/(loss) per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended Six Months Ended Six Months Ended ​ ​ June 30, 2023 ​ June 30, 2022 ​ June 30, 2023 ​ June 30, 2022 Class A Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class A Common Stock ​ $ 1,115,145 ​ $ 3,614,039 ​ $ 3,141,106 ​ $ 2,610,650 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 19,588,855 ​ ​ 20,125,000 ​ 19,745,490 ​ ​ 20,125,000 Net income/(loss) per share, Class A, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class B common stock ​ $ 278,786 ​ $ 903,510 ​ ​ 785,277 ​ ​ 652,662 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 4,902,371 ​ ​ 5,031,250 ​ 4,938,965 ​ ​ 5,031,250 Net income/(loss) per share, Class B, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13	Net Income per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The Company has two classes of common stock, one for each of its Class A Common Stock and Class B Common Stock. Income and losses are shared pro rata between the two classes of shares. Net Income per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Net Income is allocated to the Company’s Class A Common Stock and Class B Common Stock based on the relative shares outstanding for each class of common stock compared to the Company’s total shares outstanding. The Company has not considered the effect of the warrants sold in the IPO or the Private Placement Warrants in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value. The Company’s basic and diluted net income per share are calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the ​ ​ For the period from ​ ​ Year Ended ​ ​ January 4, 2021 to ​ ​ ​ December 31, 2022 ​ ​ December 31, 2021 Class A Common Stock ​ ​ ​ ​ ​ ​ Numerator: Net income allocable to Class A Common Stock ​ $ 2,783,672 ​ $ 162,830 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 20,125,000 ​ 4,947,859 Net income per share, Class A, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ Numerator: Net income allocable to Class B common stock ​ $ 695,918 ​ $ 149,288 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 5,031,250 ​ 4,536,343 Net income per share, Class B, basic and diluted ​ $ 0.14 ​ $ 0.03
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 (including deferred underwriting commissions of an aggregate of approximately $ 7,043,750 which, prior to the resignation of Barclays and waiver of fees by BMO, was to be paid to the underwriters of the IPO upon the completion of the Business Combination, but has been waived following their resignation and waiver, respectively)	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs amounted to $ 25,559,771 was charged to temporary equity, and
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ASC 815-40”). Such warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statement of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of any warrants. At that time, the portion of the warrant liabilities related to the warrants will be reclassified to additional paid-in capital.	Warrant Liabilities The Company accounts for warrants for shares of the Company’s Class A Common Stock that are not indexed to its own stock as liabilities at fair value on the balance sheet in accordance with ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity (“ ASC 815-40
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of impact of restatement on statements of operations statements of changes in stockholders' deficit and statements of cash flows	Statement of Operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended September 30, 2022 (unaudited) ​ ​ As Previously ​ Restatement ​ ​ ​ Reported Adjustment As Restated Loss from operations ​ $ 722,149 ​ $ — ​ $ 722,149 Other income (expenses): ​ ​ ​ Gain from derecognition of deferred underwriting fee payable ​ 7,043,750 ​ (6,717,612) ​ 326,138 Total other income (expenses) ​ 7,831,954 ​ (6,717,612) ​ 1,114,342 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 7,109,805 ​ $ (6,717,612) ​ $ 392,193 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding – Class A common stock ​ 20,125,000 ​ — ​ 20,125,000 Basic and diluted earnings per share – Class A common stock ​ $ 0.28 ​ $ (0.26) ​ $ 0.02 Basic and diluted weighted average shares outstanding – Class B common stock ​ 5,031,250 ​ — ​ 5,031,250 Basic and diluted earnings per share – Class B common stock ​ $ 0.28 ​ $ (0.26) ​ $ 0.02 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, 2022 (unaudited) ​ ​ As Previously ​ Restatement ​ ​ ​ Reported Adjustment As Restated Loss from operations ​ $ 5,776,498 ​ $ — ​ $ 5,776,498 Other income (expenses): ​ ​ ​ Gain from derecognition of deferred underwriting fee payable ​ 7,043,750 ​ (6,717,612) ​ 326,138 Total other income (expenses) ​ 16,149,616 ​ (6,717,612) ​ 9,432,004 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 10,373,118 ​ $ (6,717,612) ​ $ 3,655,506 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding – Class A common stock ​ 20,125,000 ​ — ​ 20,125,000 Basic and diluted earnings per share – Class A common stock ​ $ 0.41 ​ $ (0.26) ​ $ 0.15 Basic and diluted weighted average shares outstanding – Class B common stock ​ 5,031,250 ​ — ​ 5,031,250 Basic and diluted earnings per share – Class B common stock ​ $ 0.41 ​ $ (0.26) ​ $ 0.15 ​ Statement of Changes in Stockholders’ Deficit: (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Additional Accumulated Deficit Total ​ ​ Stock ​ Paid-In ​ As Previously ​ Restatement ​ ​ ​ ​ Stockholders ​ Shares Amount Capital Reported Adjustment As Restated Deficit Balance – June 30, 2022 5,031,250 ​ $ 503 ​ $ — ​ $ (12,620,313) ​ — ​ $ (12,620,313) ​ $ (12,610,810) Adjustment for accretion of Class A common stock subject to possible redemption amount — ​ — ​ — ​ (1,265,293) ​ 6,717,612 ​ 5,452,319 ​ 5,452,319 Net income — ​ — ​ — ​ 7,109,805 ​ (6,717,612) ​ 392,193 ​ 392,193 Balance – September 30, 2022 5,031,250 ​ $ 503 ​ $ — ​ $ (6,775,801) ​ $ — ​ $ (6,775,801) ​ $ (6,775,298) ​ Statement of Cash Flows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, 2022 (unaudited) ​ ​ As Previously ​ Restatement ​ ​ ​ Reported Adjustment As Restated Cash Flows from Operating Activities: ​ ​ ​ ​ ​ ​ Net income ​ $ 10,373,118 ​ $ (6,717,612) ​ $ 3,655,506 Adjustments to reconcile net income to net cash used in operating activities: ​ ​ ​ ​ Gain from derecognition of deferred underwriting fee payable ​ (7,043,750) ​ 6,717,612 ​ (326,138) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net change in cash ​ $ (621,952) ​ $ — ​ $ (621,952) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Supplemental disclosure of noncash activities: ​ ​ ​ Gain from derecognition of deferred underwriting fee payable allocated to Class A common stock ​ $ — ​ $ 6,717,612 ​ $ 6,717,612

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of company's basic and diluted net income per share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended Three Months Ended Six Months Ended Six Months Ended ​ ​ June 30, 2023 ​ June 30, 2022 ​ June 30, 2023 ​ June 30, 2022 Class A Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class A Common Stock ​ $ 1,115,145 ​ $ 3,614,039 ​ $ 3,141,106 ​ $ 2,610,650 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 19,588,855 ​ ​ 20,125,000 ​ 19,745,490 ​ ​ 20,125,000 Net income/(loss) per share, Class A, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income/(loss) allocable to Class B common stock ​ $ 278,786 ​ $ 903,510 ​ ​ 785,277 ​ ​ 652,662 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 4,902,371 ​ ​ 5,031,250 ​ 4,938,965 ​ ​ 5,031,250 Net income/(loss) per share, Class B, basic and diluted ​ $ 0.06 ​ $ 0.18 ​ $ 0.16 ​ $ 0.13	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the ​ ​ For the period from ​ ​ Year Ended ​ ​ January 4, 2021 to ​ ​ ​ December 31, 2022 ​ ​ December 31, 2021 Class A Common Stock ​ ​ ​ ​ ​ ​ Numerator: Net income allocable to Class A Common Stock ​ $ 2,783,672 ​ $ 162,830 Denominator: Weighted Average Class A Common Stock, Basic and Diluted ​ 20,125,000 ​ 4,947,859 Net income per share, Class A, basic and diluted ​ $ 0.14 ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ Class B Common Stock ​ ​ ​ ​ Numerator: Net income allocable to Class B common stock ​ $ 695,918 ​ $ 149,288 Denominator: Weighted Average Class B Common Stock, Basic and Diluted ​ 5,031,250 ​ 4,536,343 Net income per share, Class B, basic and diluted ​ $ 0.14 ​ $ 0.03

CLASS A COMMON STOCK SUBJECT _5

CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Schedule of reconciliation of Class A common stock subject to possible redemption	​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ ​ (11,247,232) Plus: ​ ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 205,275,000 Accretion of Class A common stock subject to possible redemption amount ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 207,501,604 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,558,841 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 209,060,445 Accretion of Class A common stock subject to possible redemption amount ​ ​ 1,291,243 Redemption of Class A common stock on June 29, 2023 ​ ​ (189,038,189) Class A common stock subject to possible redemption at June 30, 2023 ​ $ 21,313,499	​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering $ 201,250,000 Less: ​ ​ Fair Value of Public Warrants at Issuance ​ ​ (5,816,125) Offering Costs allocated to Class A common stock subject to possible redemption ​ (11,247,232) Plus: ​ ​ Accretion of Class A common stock subject to possible redemption amount ​ 21,088,357 Class A common stock subject to possible redemption at December 31, 2021 ​ $ 205,275,000 Accretion of Class A common stock subject to possible redemption amount, ​ ​ (4,141,008) Derecognition of deferred underwriting fee payable allocated to Class A common stock ​ ​ 6,717,612 Additional offering cost related to deferred underwriting fees ​ ​ (350,000) Class A common stock subject to possible redemption at December 31, 2022 ​ $ 207,501,604

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2022
INCOME TAXES
Schedule of significant components of the Company's deferred tax assets	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ December 31, 2021 Deferred tax asset ​ ​ Organizational costs/Startup expenses ​ $ 1,316,585 ​ $ 272,783 Total deferred tax asset ​ 1,316,585 ​ 272,783 Valuation allowance ​ (1,316,585) ​ (272,783) Deferred tax asset, net of allowance ​ $ — ​ $ —
Schedule of income tax provision	​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2022 ​ 2021 Federal: ​ ​ ​ ​ Current ​ $ 591,919 ​ $ — Deferred ​ (1,403,802) ​ (272,783) ​ ​ ​ ​ ​ ​ ​ State: ​ ​ ​ Current ​ $ — ​ $ — Deferred ​ — ​ — Change in valuation allowance ​ 1,043,802 ​ 272,783 Income tax provision ​ $ 591,919 ​ $ —
Schedule of reconciliation of the federal income tax rate to the company effective tax rate	​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, December 31, ​ ​ 2022 ​ 2021 Statutory federal income tax rate 21.0 % 21.0 % Tax effects of change in fair value of warrant liability (37.2) % (117.0) % Gain on deferred underwriting ​ (1.7) % ​ — ​ Net operating loss ​ 0.3 % ​ — ​ Tax effects of transaction costs allocated to warrant liability ​ — ​ ​ 78.0 % Change in valuation allowance 32.1 % 18.0 % Income tax provision 14.5 % — %

FAIR VALUE MEASUREMENT (Table_2

FAIR VALUE MEASUREMENT (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
FAIR VALUE MEASUREMENT
Schedule of company's assets and liabilities that are measured at fair value	​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, Description ​ Level ​ 2023 Assets: ​ ​ ​ ​ ​ Investments held in Trust Account, current 1 ​ $ 189,038,189 Investments held in Trust Account, noncurrent ​ 1 ​ $ 22,060,895 Liabilities: ​ ​ ​ ​ ​ Warrant liability – Public Warrants 2 ​ $ 292,819 Warrant liability – Private Placement Warrants 2 ​ $ 291,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000	​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description ​ Level ​ 2022 Assets: ​ ​ ​ Investments held in Trust Account 1 ​ $ 208,244,129 Liabilities: ​ ​ ​ Warrant liability – Public Warrants 1 ​ $ 1,360,450 Warrant liability – Private Placement Warrants 2 ​ $ 1,352,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, Description Level 2021 Assets: ​ ​ Investments held in Trust Account 1 ​ $ 205,284,883 Liabilities: ​ ​ Warrant liability – Public Warrants 1 ​ $ 4,943,706 Warrant liability – Private Placement Warrants 2 ​ $ 4,913,000
Schedule of change in the fair value of the warrant liabilities		​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private ​ ​ Warrant ​ ​ Placement ​ Public ​ Liabilities Fair value as of January 4, 2021 (inception) ​ $ — ​ $ — ​ $ — Initial measurement on October 4, 2021 ​ 5,780,000 ​ 5,816,125 ​ 11,596,125 Change in fair value ​ (867,000) ​ (872,419) ​ (1,739,419) Transfer to Level 1 ​ — ​ (4,943,706) ​ (4,943,706) Transfer to Level 2 ​ (4,913,000) ​ — ​ (4,913,000) Fair value as of December 31, 2021 ​ $ — ​ $ — ​ $ —

DESCRIPTION OF ORGANIZATION A_4

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)								6 Months Ended	12 Months Ended
	Dec. 14, 2022	Sep. 02, 2022 USD ($) shares	Mar. 28, 2022 USD ($) $ / shares shares	Oct. 04, 2021 USD ($) $ / shares shares	Mar. 16, 2021 $ / shares shares	Jan. 05, 2021 $ / shares shares	Jan. 04, 2021 item	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Jun. 29, 2023 $ / shares	Jul. 20, 2022 USD ($)	Jul. 14, 2022 USD ($)	Mar. 28, 2022 EUR (€)
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Condition for future business combination number of businesses minimum | item							1
Sale of units, net of underwriting discounts (in shares)								13,020,000	13,020,000
Purchase price, per unit | $ / shares								$ 10	$ 10
Number of shares no longer subject to forfeiture								656,250	656,250
Proceeds from issuance of units | $								$ 130,200,000	$ 130,200,000
Proceeds from issuance of private placement warrants | $										$ 10,000,000
Underwriting commissions | $												$ 2,465,312	$ 4,578,438
Deferred underwriting fee payable | $										6,693,750
Other offering costs | $								$ 13,158,021	$ 13,158,021
Payments for investment of cash in trust account | $										205,275,000
Condition for future business combination use of proceeds percentage								80	80
Condition for future business combination threshold percentage ownership								50	50
Maximum allowed dissolution expenses | $								$ 100,000	$ 100,000
Obligation to redeem public shares if entity does not complete a business combination (as a percent)								100%	100%
Cash | $								$ 51,409	$ 160,940	953,329
Working capital deficit | $								6,999,802	5,942,600
Issuance costs | $										$ 548,505
Working capital loans | $								$ 0	$ 0
Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount in excess of gross proceeds | $			$ 100,000,000
Closing share valuation | $		$ 500,000,000
Minimum closing cash consideration after transaction expenses and redemptions | $			$ 12,500,000
Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sponsor forfeited common stock					1,618,434
Issuance of Class B common stock to Sponsor (in shares)					1,618,434
Purchase price | $ / shares					$ 0.006			$ 8.54	$ 8.54
Common stock, conversion basis									1
PubCo | Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Minimum percentage of redemption on outstanding shares of common stock for issuing additional cash consideration			85%
Maximum percentage of redemption on outstanding shares of common stock for issuing deferred cash consideration			85%
Deferred share consideration			12,254,902
Earnout consideration			10,000,000
Novibet
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Shares converted			1
Komisium Limited | Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Minimum percentage of redemption on outstanding shares of common stock for issuing additional cash consideration		85%
Maximum percentage of redemption on outstanding shares of common stock for issuing deferred cash consideration		85%
Maximum percentage pf shares to be transferred	10%		30%
Maximum amount of divided to be paid | €														€ 3,579,625
Komisium Limited | PubCo | Business Combination Agreement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Closing cash consideration | $			$ 50,000,000
Closing share consideration | $			$ 500,000,000
Price per share | $ / shares			$ 10.20
Initial Share Premium | $			$ 598,000
Deferred share consideration			12,254,902
Number of shares to be retained			65,000
Number of shares issuable		12,254,902
Class B common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price, per unit | $ / shares						$ 0.006
Number of shares no longer subject to forfeiture					5,031,250
Issuance of Class B common stock to Sponsor (in shares)					5,031,250	25,000
Common stock, par value (in dollars per share) | $ / shares								0.0001	$ 0.0001	$ 0.0001
Class B common stock | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sponsor forfeited common stock				1,618,434
Purchase price | $ / shares				$ 0.006
Class A common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares in a unit				1
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001				0.0001	0.0001	$ 0.0001
PubCo Ordinary Share
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Shares converted in to the rights of the holder			1
Conversion of shares exercisable			1
Anchor Investor Warrants | Class B common stock | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares)				1,618,434
Purchase price | $ / shares				$ 0.006
Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price | $ / shares								9.20	$ 9.20
Public Warrants | Class A common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of warrants in a unit				0.5
Sponsor
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price | $ / shares								$ 0.035			$ 0.105
Issuance costs | $								$ 25,000	$ 25,000
Sponsor | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares)				1,618,434	1,618,434	4,312,500
Sponsor | Class B common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sponsor forfeited common stock				1,618,434
Issuance of Class B common stock to Sponsor (in shares)						4,312,500
Common stock, par value (in dollars per share) | $ / shares						$ 0.0001
Sponsor | Class A common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares)						4,312,500
Sponsor | Anchor Investor Warrants | Class B common stock
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issuance of Class B common stock to Sponsor (in shares)				1,618,434
Purchase price | $ / shares				$ 0.006
Initial Public Offering
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)				20,125,000
Purchase price, per unit | $ / shares				$ 10.20
Proceeds from issuance initial public offering | $				$ 201,250,000
Transaction costs | $				25,559,771
Underwriting fees | $				3,825,000
Underwriting commissions | $				7,043,750				7,043,750	7,043,750
Other offering costs | $				894,595				$ 1,154,518	$ 1,154,518
Offering cost related to founder shares | $				13,796,426
Offering cost related to equity | $				13,158,021
Offering cost | $				638,405
Payments for investment of cash in trust account | $				$ 205,275,000
Threshold percentage of public shares subject to redemption without company's prior written consent								15%	15%
Issuance costs | $								$ 25,559,771	$ 25,559,771
Initial Public Offering | Founder Shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)					20,125,000
Percentage of founder shares issued and outstanding					20%
Initial Public Offering | Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares in a unit				1
Number of warrants in a unit				0.50
Number of shares per warrant				1
Initial Public Offering | Sponsor
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)								2,732,500	2,732,500
Purchase price, per unit | $ / shares								$ 10	$ 10
Proceeds from issuance of units | $								$ 27,325,000	$ 27,325,000
Private Placement | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)				8,000,000				8,000,000
Price of warrant | $ / shares				$ 1				$ 1
Proceeds from issuance of private placement warrants | $				$ 8,000,000				$ 8,000,000
Private Placement | Anchor Investor Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)				2,000,000
Price of warrant | $ / shares				$ 1				$ 1
Proceeds from issuance of private placement warrants | $				$ 2,000,000
Private Placement | Sponsor | Anchor Investor Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)								2,000,000	2,000,000
Over-allotment option
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)				2,625,000
Purchase price, per unit | $ / shares				$ 10
Over-allotment option | Anchor Investor Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Proceeds from issuance of private placement warrants | $				$ 2,000,000				$ 2,000,000

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)	3 Months Ended					6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Statement of Operations:
Loss from operations			$ 722,149					$ 5,776,497
Other income (expense)
Gain from recognition of deferred underwriting fee payable			326,138					326,138	$ 326,138
Total other income (expenses)	$ 2,426,954		1,114,342	$ 5,299,463		$ 5,964,242	$ 8,317,661	9,432,004	10,540,962	$ 594,784
Net income	1,393,931	$ 2,532,453	392,193	4,517,549	$ (1,254,236)	3,926,383	3,263,313	3,655,506	3,479,590	312,118
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the beginning	(6,938,913)	(7,912,525)	(12,619,810)	(16,787,359)	(15,533,123)	(7,912,525)	(15,533,123)	(15,533,123)	(15,533,123)	0
Accretion of Class A common stock subject to possible redemption amount	(1,291,243)	(1,558,841)	5,452,319	(350,000)					4,141,008	(20,738,357)
Net income	1,393,931	2,532,453	392,193	4,517,549	(1,254,236)	3,926,383	3,263,313	3,655,506	3,479,590	312,118
Balance at the end	(6,836,225)	(6,938,913)	(6,775,298)	(12,619,810)	(16,787,359)	(6,836,225)	(12,619,810)	(6,775,298)	(7,912,525)	(15,533,123)
Cash flows from operating activities:
Net income						3,926,383	3,263,313	3,655,506	3,479,590	312,118
Adjustments to reconcile net income to net cash used in operating activities:
Gain from derecognition of deferred underwriting fee payable			(326,138)					(326,138)	(326,138)
Net Change in Cash						(109,531)	(456,257)	621,952	(792,389)	953,329
Supplemental disclosure of noncash activities:
Gain from derecognition of deferred underwriting fee payable allocated to Class A common stock								6,717,612
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the beginning					0		0	0	0	0
Accretion of Class A common stock subject to possible redemption amount										(4,892,613)
Balance at the end										0
Accumulated Deficit
Other income (expense)
Net income	1,393,931	2,532,453	392,193	4,517,549	(1,254,236)				3,479,590	312,118
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the beginning	(6,939,416)	(7,913,028)	(12,620,313)	(16,787,862)	(15,533,626)	(7,913,028)	(15,533,626)	(15,533,626)	(15,533,626)	0
Accretion of Class A common stock subject to possible redemption amount	(1,291,243)	(1,558,841)	5,452,319	(350,000)					4,141,008	(15,845,744)
Net income	1,393,931	2,532,453	392,193	4,517,549	(1,254,236)				3,479,590	312,118
Balance at the end	$ (6,836,728)	(6,939,416)	(6,775,801)	(12,620,313)	(16,787,862)	$ (6,836,728)	(12,620,313)	(6,775,801)	$ (7,913,028)	$ (15,533,626)
As previously Reported | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member]
Statement of Operations:
Loss from operations			722,149					5,776,497
Other income (expense)
Gain from recognition of deferred underwriting fee payable			7,043,750					7,043,750
Total other income (expenses)			7,831,954					16,149,616
Net income			7,109,805					10,373,118
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income			7,109,805					10,373,118
Cash flows from operating activities:
Net income								10,373,118
Adjustments to reconcile net income to net cash used in operating activities:
Gain from derecognition of deferred underwriting fee payable			(7,043,750)					(7,043,750)
Net Change in Cash								621,952
As previously Reported | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member] | Accumulated Deficit
Other income (expense)
Net income			7,109,805
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the beginning			(12,620,313)
Accretion of Class A common stock subject to possible redemption amount			(1,265,293)
Net income			7,109,805
Balance at the end			(6,775,801)	$ (12,620,313)			$ (12,620,313)	(6,775,801)
Restatement Adjustment | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member]
Other income (expense)
Gain from recognition of deferred underwriting fee payable			(6,717,612)					(6,717,612)
Total other income (expenses)			(6,717,612)					(6,717,612)
Net income			(6,717,612)					(6,717,612)
Increase (Decrease) in Stockholders' Equity (Deficit)
Net income			(6,717,612)					(6,717,612)
Cash flows from operating activities:
Net income								(6,717,612)
Adjustments to reconcile net income to net cash used in operating activities:
Gain from derecognition of deferred underwriting fee payable			6,717,612					6,717,612
Supplemental disclosure of noncash activities:
Gain from derecognition of deferred underwriting fee payable allocated to Class A common stock								$ 6,717,612
Restatement Adjustment | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member] | Accumulated Deficit
Other income (expense)
Net income			(6,717,612)
Increase (Decrease) in Stockholders' Equity (Deficit)
Accretion of Class A common stock subject to possible redemption amount			6,717,612
Net income			$ (6,717,612)
Common Class A [Member]
Other income (expense)
Weighted average shares of common stock outstanding, basic	19,588,855		20,125,000	20,125,000		19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Weighted average shares of common stock outstanding, diluted	19,588,855		20,125,000	20,125,000		19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Basic net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Common Class A [Member] | Common Stock
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the end	$ 341					$ 341
Balance at the end (in shares)	3,412,816					3,412,816
Common Class A [Member] | As previously Reported | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member]
Other income (expense)
Weighted average shares of common stock outstanding, basic			20,125,000					20,125,000
Weighted average shares of common stock outstanding, diluted			20,125,000					20,125,000
Basic net income per share			$ 0.28					$ 0.41
Diluted net income per share			0.28					0.41
Common Class A [Member] | Restatement Adjustment | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member]
Other income (expense)
Basic net income per share			(0.26)					(0.26)
Diluted net income per share			$ (0.26)					$ (0.26)
Common Class B [Member]
Other income (expense)
Weighted average shares of common stock outstanding, basic	4,902,371		5,031,250	5,031,250		4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Weighted average shares of common stock outstanding, diluted	4,902,371		5,031,250	5,031,250		4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Basic net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06		$ 0.02	$ 0.18		$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Common Class B [Member] | Common Stock
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the beginning	$ 503	$ 503	$ 503	$ 503	$ 503	$ 503	$ 503	$ 503	$ 503	$ 0
Balance at the beginning (in shares)	5,031,250	5,031,250	5,031,250	5,031,250	5,031,250	5,031,250	5,031,250	5,031,250	5,031,250	0
Balance at the end	$ 162	$ 503		$ 503	$ 503	$ 162	$ 503		$ 503	$ 503
Balance at the end (in shares)	1,618,434	5,031,250		5,031,250	5,031,250	1,618,434	5,031,250		5,031,250	5,031,250
Common Class B [Member] | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member] | Common Stock
Increase (Decrease) in Stockholders' Equity (Deficit)
Balance at the beginning			$ 503
Balance at the beginning (in shares)			5,031,250
Balance at the end			$ 503	$ 503			$ 503	$ 503
Balance at the end (in shares)			5,031,250	5,031,250			5,031,250	5,031,250
Common Class B [Member] | As previously Reported | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member]
Other income (expense)
Weighted average shares of common stock outstanding, basic			5,031,250					5,031,250
Weighted average shares of common stock outstanding, diluted			5,031,250					5,031,250
Basic net income per share			$ 0.28					$ 0.41
Diluted net income per share			0.28					0.41
Common Class B [Member] | Restatement Adjustment | Extinguishment of Contingent Liability as Credit To Stockholder's Deficit [Member]
Other income (expense)
Basic net income per share			(0.26)					(0.26)
Diluted net income per share			$ (0.26)					$ (0.26)

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Jul. 20, 2022	Jul. 14, 2022	Oct. 04, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents	$ 0	$ 0	$ 0	$ 0
Deferred tax asset	1,589,736	1,316,585	272,783	272,783
Unrecognized tax benefits	0	0	0	0
Unrecognized tax benefits accrued for interest and penalties	0	0	0	0
Offering costs			$ 548,505
Underwriting commissions					$ 2,465,312	$ 4,578,438
Offering costs charged to temporary equity	10,897,232	10,897,232		$ (11,247,232)
Other offering costs	13,158,021	13,158,021
Additional deferred underwriting fees		350,000
Initial Public Offering
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Offering costs	25,559,771	25,559,771
Underwriting commissions	7,043,750	7,043,750					$ 7,043,750
Other offering costs	$ 1,154,518	$ 1,154,518					$ 894,595
Class A common stock subject to redemption
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Ordinary shares, shares subject to possible redemption	20,125,000	20,125,000	20,125,000	20,125,000
Offering costs charged to temporary equity				$ (11,247,232)
Class A common stock subject to redemption | Initial Public Offering
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Ordinary shares, shares subject to possible redemption	20,125,000	20,125,000

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) per Share of Common Stock (Details) - USD ($)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Class A common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Numerator: Net income allocable to Class A Common Stock	$ 1,115,145		$ 3,614,039	$ 3,141,106	$ 2,610,650		$ 2,783,672	$ 162,830
Weighted average shares of common stock outstanding, basic	19,588,855	20,125,000	20,125,000	19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Weighted average shares of common stock outstanding, diluted	19,588,855	20,125,000	20,125,000	19,745,490	20,125,000	20,125,000	20,125,000	4,947,859
Basic net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Class B common stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Numerator: Net income allocable to Class A Common Stock	$ 278,786		$ 903,510	$ 785,277	$ 652,662		$ 695,918	$ 149,288
Weighted average shares of common stock outstanding, basic	4,902,371	5,031,250	5,031,250	4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Weighted average shares of common stock outstanding, diluted	4,902,371	5,031,250	5,031,250	4,938,965	5,031,250	5,031,250	5,031,250	4,536,343
Basic net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03
Diluted net income per share	$ 0.06	$ 0.02	$ 0.18	$ 0.16	$ 0.13	$ 0.15	$ 0.14	$ 0.03

INITIAL PUBLIC OFFERING (Deta_2

INITIAL PUBLIC OFFERING (Details) - $ / shares		6 Months Ended	12 Months Ended
	Oct. 04, 2021	Jun. 30, 2023	Dec. 31, 2022
INITIAL PUBLIC OFFERING
Number of units sold		13,020,000	13,020,000
Purchase price, per unit		$ 10	$ 10
Initial Public Offering
INITIAL PUBLIC OFFERING
Number of units sold	20,125,000
Purchase price, per unit	$ 10.20
Initial Public Offering | Public Warrants
INITIAL PUBLIC OFFERING
Number of shares in a unit	1
Number of warrants in a unit	0.50
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Over-allotment option
INITIAL PUBLIC OFFERING
Number of units sold	2,625,000
Purchase price, per unit	$ 10

PRIVATE PLACEMENT (Details)_2

PRIVATE PLACEMENT (Details) - USD ($)		6 Months Ended	12 Months Ended
	Oct. 04, 2021	Jun. 30, 2023	Dec. 31, 2021
PRIVATE PLACEMENT
Aggregate purchase price			$ 10,000,000
Private Placement | Private Placement Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	8,000,000	8,000,000
Price of warrants	$ 1	$ 1
Aggregate purchase price	$ 8,000,000	$ 8,000,000
Private Placement | Anchor Investor Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	2,000,000
Price of warrants	$ 1	$ 1
Aggregate purchase price	$ 2,000,000

RELATED PARTY TRANSACTIONS - _2

RELATED PARTY TRANSACTIONS - Founder Shares (Details)				6 Months Ended	12 Months Ended
	Oct. 04, 2021 shares	Mar. 16, 2021 $ / shares shares	Jan. 05, 2021 USD ($) shares	Jun. 30, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) D $ / shares	Dec. 31, 2021 USD ($)	Jun. 29, 2023 $ / shares
RELATED PARTY TRANSACTIONS
Aggregate purchase price | $						$ 25,000
Sponsor
RELATED PARTY TRANSACTIONS
Purchase price | $ / shares				$ 0.035			$ 0.105
Founder Shares
RELATED PARTY TRANSACTIONS
Stock sold		1,618,434
Aggregate purchase price | $				$ 13,796,426	$ 13,796,426
Sponsor forfeited common stock		1,618,434
Purchase price | $ / shares		$ 0.006		$ 8.54	$ 8.54
Founder Shares | Sponsor
RELATED PARTY TRANSACTIONS
Stock sold	1,618,434	1,618,434	4,312,500
Aggregate purchase price | $			$ 25,000
Common shares, shares outstanding (in shares)		5,031,250
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares				$ 12	$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination				20	20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination				30	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences				150 days	150 days

RELATED PARTY TRANSACTIONS - _3

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)			3 Months Ended	6 Months Ended		12 Months Ended
	Oct. 04, 2021	Sep. 30, 2021	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Jan. 05, 2021
RELATED PARTY TRANSACTIONS
Repayment of promissory note - related party								$ 162,892
Promissory Note with Related Party
RELATED PARTY TRANSACTIONS
Maximum borrowing capacity of related party promissory note									$ 300,000
Repayment of promissory note - related party	$ 162,892					$ 162,892
Administrative Support Agreement
RELATED PARTY TRANSACTIONS
Expenses per month		$ 10,000
Expenses incurred and paid			$ 30,000	$ 60,000	$ 30,000	120,000		$ 30,000
Related Party Loans | Working capital loans warrant
RELATED PARTY TRANSACTIONS
Loan conversion agreement warrant			$ 1,500,000	$ 1,500,000		$ 1,500,000
Price of warrant			$ 1	$ 1		$ 1
Expenses incurred and paid				$ 0		$ 0	$ 0

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Details)	3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) item $ / shares	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) item $ / shares
COMMITMENTS AND CONTINGENCIES
Maximum number of demands for registration of securities | item		3		3
Deferred fee per unit | $ / shares		$ 0.35		$ 0.35
Aggregate deferred underwriting fee payable		$ 7,043,750		$ 7,043,750
Gain from recognition of deferred underwriting fee payable	$ 326,138		$ 326,138	$ 326,138

WARRANT LIABILITIES (Details)_2

WARRANT LIABILITIES (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 D $ / shares shares	Dec. 31, 2022 D $ / shares shares
WARRANT LIABILITIES
Threshold period for filling registration statement after business combination	15 days	15 days
Period of time within which registration statement is expected to become effective	60 days	60 days
Stock price trigger for redemption of public warrants	$ 9.20	$ 9.20
Adjustment of exercise price of warrants based on market value (as a percent)	115%	115%
Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00
WARRANT LIABILITIES
Stock price trigger for redemption of public warrants	$ 18	$ 18
Percentage of adjustment of redemption price of stock based on market value.	180%	180%
Redemption of Public Warrants for Cash
WARRANT LIABILITIES
Redemption price per public warrant (in dollars per share)	$ 0.01	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days	30 days
Stock price trigger for redemption of public warrants	$ 18	$ 18
Threshold trading days for redemption of public warrants	20 days	20 days
Threshold consecutive trading days for redemption of public warrants | D	30	30
Threshold number of business days before sending notice of redemption to warrant holders | D	3	3
Redemption of Warrants for Class A Common Stock
WARRANT LIABILITIES
Redemption price per public warrant (in dollars per share)	$ 0.10	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days	30 days
Stock price trigger for redemption of public warrants	$ 10	$ 10
Threshold consecutive trading days for redemption of public warrants | D	30	30
Warrants
WARRANT LIABILITIES
Warrants outstanding | shares	20,062,500	20,062,500
Warrants expiration term	5 years	5 years
Public Warrants
WARRANT LIABILITIES
Warrants outstanding | shares	10,062,500	10,062,500
Warrants exercisable term from the completion of business combination	30 days	30 days
Warrants expiration term	5 years	5 years
Warrants exercisable for cash | shares		0
Threshold consecutive trading days for redemption of public warrants | D	20	20
Share Price	$ 9.20	$ 9.20
Percentage of gross proceeds on total equity proceeds	60%	60%
Private Placement Warrants
WARRANT LIABILITIES
Warrants outstanding | shares	10,000,000	10,000,000

CLASS A COMMON STOCK SUBJECT _6

CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)	3 Months Ended				6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($) Vote shares	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) Vote shares	Dec. 31, 2022 USD ($) Vote $ / shares shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2021 USD ($) shares
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Offering Costs allocated to Class A common stock subject to possible redemption					$ 10,897,232	$ 10,897,232		$ (11,247,232)
Additional deferred underwriting fees						350,000
Accretion of Class A common stock subject to possible redemption amount	$ 1,291,243	$ 1,558,841	$ (5,452,319)	$ 350,000		(4,141,008)	$ 20,738,357
Derecognition of deferred underwriting fee payable allocated to Class A common stock						$ 6,717,612
Class A common stock subject to redemption
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Temporary equity, shares authorized | shares	380,000,000				380,000,000
Ordinary shares, shares subject to possible redemption | shares	20,125,000				20,125,000	20,125,000	20,125,000	20,125,000
Gross proceeds from Initial Public Offering								$ 201,250,000
Fair Value of Public Warrants at Issuance								(5,816,125)
Offering Costs allocated to Class A common stock subject to possible redemption								(11,247,232)
Accretion of Class A common stock subject to possible redemption amount	$ 1,291,243	1,558,841				$ (4,141,008)		21,088,357
Derecognition of deferred underwriting fee payable allocated to Class A common stock						6,717,612
Additional offering cost related to deferred underwriting fees						(350,000)
Class A common stock subject to possible redemption	$ 21,313,499	$ 209,060,445			$ 21,313,499	$ 207,501,604	$ 205,275,000	$ 205,275,000
Class A common stock
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
Temporary equity, shares authorized | shares						380,000,000
Temporary equity, par value | $ / shares						$ 0.0001
Common shares, votes per share | Vote	1				1	1

STOCKHOLDERS' DEFICIT - Preferr

STOCKHOLDERS' DEFICIT - Preferred Stock Shares (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
STOCKHOLDER'S DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0	0
Preferred shares, shares outstanding	0	0	0

STOCKHOLDERS' DEFICIT - Common

STOCKHOLDERS' DEFICIT - Common Stock Shares (Details)	Jun. 30, 2023 Vote $ / shares shares	Jun. 29, 2023 shares	Dec. 31, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares	Oct. 04, 2021 $ / shares
Class A common stock
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares authorized (in shares)	380,000,000		380,000,000	380,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1		1
Common shares, shares issued (in shares)	3,412,816		0
Common shares, shares outstanding (in shares)	3,412,816		0
Class A common stock not subject to possible redemption
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares issued (in shares)			0	0
Common shares, shares outstanding (in shares)			0	0
Class A common stock subject to possible redemption
STOCKHOLDER'S EQUITY/(DEFICIT)
Common stock subject to possible redemption	2,112,027		20,125,000	20,125,000
Class B common stock
STOCKHOLDER'S EQUITY/(DEFICIT)
Common shares, shares authorized (in shares)	20,000,000		20,000,000	20,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1		1
Common shares, shares issued (in shares)	1,618,434		5,031,250	5,031,250
Common shares, shares outstanding (in shares)	1,618,434	1,618,434	5,031,250	5,031,250

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details)				6 Months Ended	12 Months Ended
	Oct. 04, 2021 $ / shares shares	Mar. 16, 2021 $ / shares shares	Jan. 05, 2021 shares	Jun. 30, 2023 $ / shares	Dec. 31, 2022 $ / shares
Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Shares subject to forfeiture		1,618,434
Stock sold		1,618,434
Share Price | $ / shares		$ 0.006		$ 8.54	$ 8.54
Common stock, conversion basis					1
Class B common stock
STOCKHOLDER'S EQUITY/(DEFICIT)
Stock sold		5,031,250	25,000
Ratio to be applied to the stock in the conversion				25	25
Class B common stock | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Shares subject to forfeiture	1,618,434
Share Price | $ / shares	$ 0.006
Class B common stock | Anchor Investor Warrants | Founder Shares
STOCKHOLDER'S EQUITY/(DEFICIT)
Stock sold	1,618,434
Share Price | $ / shares	$ 0.006

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2023
INCOME TAXES
Deferred tax asset	$ 1,316,585	$ 272,783	$ 1,589,736
Change in valuation allowance	$ 1,043,802	$ 272,783

INCOME TAXES - Deferred tax (De

INCOME TAXES - Deferred tax (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Deferred tax asset
Organizational costs/Startup expenses		$ 1,316,585	$ 272,783
Total deferred tax asset	$ 1,589,736	1,316,585	272,783
Valuation allowance		$ (1,316,585)	$ (272,783)

INCOME TAXES - Income tax provi

INCOME TAXES - Income tax provision (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Federal:
Current			$ 591,919
Deferred			(1,403,802)	$ (272,783)
Change in valuation allowance			1,043,802	$ 272,783
Income tax provision	$ 805,478	$ 1,225,175	$ 591,919

INCOME TAXES - Reconciliation (

INCOME TAXES - Reconciliation (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
INCOME TAXES
Statutory federal income tax rate	21%	21%
Tax effects of change in fair value of warrant liability	(37.20%)	(117.00%)
Gain on deferred underwriting	(1.70%)
Net operating loss	0.30%
Tax effects of transaction costs allocated to warrant liability		78%
Change in valuation allowance	32.10%	18%
Income tax provision	14.50%

FAIR VALUE MEASUREMENT - Comp_2

FAIR VALUE MEASUREMENT - Company's assets and liabilities that are measured at fair value (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Assets:
Investments held in Trust Account	$ 22,060,895	$ 208,244,129	$ 205,284,883
Liabilities:
Warrant liability			9,856,706
Level 1
Assets:
Investments held in Trust Account	22,060,895	208,244,129	205,284,883
Level 1 | Public Warrants
Liabilities:
Warrant liability		1,360,450	4,943,706
Level 2 | Public Warrants
Liabilities:
Warrant liability	292,819
Level 2 | Private Placement Warrants
Liabilities:
Warrant liability	$ 291,000	$ 1,352,000	$ 4,913,000

FAIR VALUE MEASUREMENT - Change

FAIR VALUE MEASUREMENT - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Jun. 30, 2023	Dec. 31, 2022
Fair value measurement
Fair value as of beginning	$ 0
Initial measurement	11,596,125
Change in fair value	(1,739,419)
Warrant liabilities	$ 9,856,706
Level 1
Fair value measurement
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants
Transfer to Level 1 and Level 2	$ (4,943,706)
Level 2
Fair value measurement
Transfer to Level 1 and Level 2	(4,913,000)
Fair value as of ending	0
Private Placement
Fair value measurement
Fair value as of beginning	0
Initial measurement	5,780,000
Change in fair value	$ (867,000)
Private Placement | Level 1
Fair value measurement
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants
Private Placement | Level 2
Fair value measurement
Transfer to Level 1 and Level 2	$ (4,913,000)
Fair value as of ending	0
Warrant liabilities	4,913,000	$ 291,000	$ 1,352,000
Public
Fair value measurement
Fair value as of beginning	0
Initial measurement	5,816,125
Change in fair value	$ (872,419)
Public | Level 1
Fair value measurement
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants
Transfer to Level 1 and Level 2	$ (4,943,706)
Warrant liabilities	4,943,706		$ 1,360,450
Public | Level 2
Fair value measurement
Fair value as of ending	$ 0
Warrant liabilities		$ 292,819